<SEC-DOCUMENT>0001100682-25-000009.txt : 20250219
<SEC-HEADER>0001100682-25-000009.hdr.sgml : 20250219
<ACCEPTANCE-DATETIME>20250219071951
ACCESSION NUMBER:		0001100682-25-000009
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250219
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250219
DATE AS OF CHANGE:		20250219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
		CENTRAL INDEX KEY:			0001100682
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				061397316
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15943
		FILM NUMBER:		25637173

	BUSINESS ADDRESS:	
		STREET 1:		251 BALLARDVALE ST
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887
		BUSINESS PHONE:		781-222-6000

	MAIL ADDRESS:	
		STREET 1:		251 BALLARDVALE ST
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHARLES RIVER LABORATORIES INTERNATIONAL INC
		DATE OF NAME CHANGE:	20000605

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHARLES RIVER LABORATORIES HOLDINGS INC
		DATE OF NAME CHANGE:	19991208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>crl-20250219.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2bfcba33-e4d6-4d05-a3ee-de26c6bf2564,g:15641a46-7146-4bba-bb0d-a06ccb9a1577,d:f42f0907e2ac4c99908bdbbbfb220a59-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>crl-20250219</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001100682</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="crl-20250219.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001100682</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-19</xbrli:startDate><xbrli:endDate>2025-02-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if42f0907e2ac4c99908bdbbbfb220a59_1"></div><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">February 19, 2025</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported)</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Charter)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.064%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.892%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-15943</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">06-1397316</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other<br/>Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">251 Ballardvale Street</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Wilmington</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Massachusetts</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">01887</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">781</ix:nonNumeric>-<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">222-6000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.943%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.945%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-13">Common stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-14">CRL</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-15">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.222%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-18">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-19">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR&#160;&#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if42f0907e2ac4c99908bdbbbfb220a59_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="-sec-extract:summary;margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.02.  Results of Operations and Financial Condition </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 19, 2025, Charles River Laboratories International, Inc. issued a press release providing financial results for the fourth quarter and fiscal year ended December 28, 2024.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The press release, attached as an exhibit to this report, includes "safe harbor" language pursuant to the Private Securities Litigation Reform Act of 1995, as amended, indicating that certain statements contained in the press release are "forward-looking" rather than historic. The press release also states that these and other risks relating to Charles River are set forth in the documents filed by Charles River with the Securities and Exchange Commission.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.01.  Financial Statements and Exhibits</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:77.994%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="crl4q24earningsrelease.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="crl4q24earningsrelease.htm">Press release dated February 19, 2025</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="if42f0907e2ac4c99908bdbbbfb220a59_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.740%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:65.080%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 19, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Matthew L. Daniel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Daniel, Corporate Senior Vice President,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Counsel, Corporate Secretary &amp; Chief Compliance Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>crl4q24earningsrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_1"></div><div style="min-height:63pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> Exhibit 99.1</font></div></div><div style="padding-left:216pt;text-indent:36pt"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:227px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NEWS RELEASE</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CHARLES RIVER LABORATORIES ANNOUNCES FOURTH-QUARTER </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AND FULL-YEAR 2024 RESULTS AND PROVIDES 2025 GUIDANCE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8211; Fourth-Quarter Revenue of $1.00 Billion </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">and Full-Year Revenue of $4.05 Billion &#8211;</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8211; Fourth-Quarter GAAP Loss per Share of $(4.22)<br>and Non-GAAP Earnings per Share of $2.66 &#8211;</font></div><div style="margin-bottom:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8211; Full-Year GAAP Earnings per Share of $0.20<br>and Non-GAAP Earnings per Share of $10.32 &#8211;</font></div><div style="margin-bottom:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8211; Provides 2025 Guidance &#8211;</font></div><div style="margin-bottom:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8211; Company Plans Stock Repurchases of <br>Approximately $350 Million in 2025 &#8211;</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WILMINGTON, MA, February&#160;19, 2025</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; Charles River Laboratories International, Inc. (NYSE&#58; CRL) today reported its results for the fourth quarter and full-year 2024 and provided guidance for 2025.  For the quarter, revenue was $1.00 billion, a decrease of 1.1% from $1.01 billion in the fourth quarter of 2023.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The impact of foreign currency translation reduced reported revenue by 0.1%, and an acquisition contributed 0.9% to consolidated fourth-quarter revenue.  A divestiture reduced reported revenue by 0.1%.  Excluding the effect of these items, revenue declined 1.8% on an organic basis.  On a segment basis, organic revenue growth in the Manufacturing Solutions (Manufacturing) segment was more than offset by lower revenue in the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the fourth quarter of 2024, the GAAP operating margin decreased to (16.7)% from 13.1% in the fourth quarter of 2023.  The primary driver of the GAAP decrease was a non-cash goodwill impairment of $215.0 million in the fourth quarter of 2024 related to the Biologics Solutions reporting unit, which includes the Biologics Testing and CDMO businesses.   On a non-GAAP basis, the fourth-quarter operating margin increased to 19.9% from 19.1%, due primarily to </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">higher revenue and operating income in the Manufacturing segment and lower unallocated corporate costs.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On a GAAP basis, the net loss available to common shareholders for the fourth quarter of 2024 was $(215.7) million, or $(4.22) per share, a decrease from net earnings of $187.1 million, or $3.62 per diluted share, for the same period in 2023.  The GAAP decreases were primarily driven by the non-cash goodwill impairment, which totaled $4.20 per share, as well as a loss of $0.32 per share on certain venture capital and other strategic investments.  This compares to a gain of $2.04 per share on certain venture capital and other strategic investments in the fourth quarter of 2023, which included a gain on our original strategic investment in Noveprim Group.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On a non-GAAP basis, net income was $136.6 million for the fourth quarter of 2024, an increase of 7.4% from $127.2 million for the same period in 2023.  Fourth-quarter diluted earnings per share on a non-GAAP basis were $2.66, an increase of 8.1% from $2.46 per share for the fourth quarter of 2023.  The increases in non-GAAP net income and earnings per share were driven by higher operating income, as well as favorable below-the-line items, including reductions in the tax rate, interest expense, and diluted shares outstanding.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">James C. Foster, Chair, President and Chief Executive Officer, said, &#8220;Throughout 2024, we have launched initiatives to generate more revenue, aggressively reduce costs, and further strengthen our business.  As we move into 2025, we see many of our global biopharmaceutical clients continuing to move forward with their restructuring and pipeline reprioritization activities, which are expected to constrain early-stage spending by many of these clients again in 2025.  We believe these trends are stabilizing, and therefore, our view of the global biopharmaceutical demand environment remains unchanged.  In addition, small and mid-sized biotechnology clients continued to benefit from a more favorable funding environment in 2024, and we expect biotechnology demand trends will be stable to slightly improved this year.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;During this period of softer demand, we remain committed to executing on our revenue and cost-savings initiatives and protecting shareholder value.  We are taking decisive actions to emerge from this period as a stronger, leaner, and more profitable company, and an even more responsive partner for our clients,&#8221; Mr. Foster concluded.</font></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_4"></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Fourth-Quarter Segment Results</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Research Models and Services (RMS)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Revenue for the RMS segment was $204.3 million in the fourth quarter of 2024, an increase of 4.3% from $195.8 million in the fourth quarter of 2023.  The Noveprim acquisition in November 2023 contributed 4.8% to fourth-quarter RMS reported revenue, and the impact of foreign currency translation reduced revenue by 0.1%.  Organic revenue decreased by 0.4%, due primari</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ly to lower revenue for research models services and the Cell Solutions business, as well </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as lower sales for non-human primates (NHPs) in China.  The decline was partially offset by higher sales of small research models, principally driven by higher pricing.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the fourth quarter of 2024, the RMS segment&#8217;s GAAP operating margin decreased to 6.7% from 18.9% in the fourth quarter of 2023.  On a non-GAAP basis, the operating margin decreased to 22.8% from 23.1%.  The GAAP and non-GAAP operating margin declines were primarily driven by research models services and NHP sales, partially offset by higher pricing for small research models and from cost savings associated with restructuring initiatives.  On a GAAP basis, the lower operating margin also reflects higher costs associated with the Company&#8217;s restructuring initiatives, including severance and site consolidation costs, as well as higher amortization expense related to the Noveprim acquisition.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Discovery and Safety Assessment (DSA)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Revenue for the DSA segment was $603.3 million in the fourth quarter of 2024, a decrease of 3.6% from $625.8 million in the fourth quarter of 2023.  The divestiture of a small Safety Assessment site reduced reported revenue by 0.2% and the impact of foreign currency translation increased DSA revenue by 0.1%.  Organic revenue decreased by 3.5%, driven primarily by lower sales volume, as well as slightly lower pricing.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the fourth quarter of 2024, the DSA segment&#8217;s GAAP operating margin decreased to 10.4% from 20.2% in the fourth quarter of 2023.  On a non-GAAP basis, the operating margin decreased to 24.7% from 26.0% in the fourth quarter of 2023.  The GAAP and non-GAAP operating margin declines were primarily driven by lower revenue, partially offset by cost savings associated with restructuring initiatives.  On a GAAP basis, the lower operating margin also reflects an NHP inventory write down, as well as higher acquisition-related adjustments associated with Noveprim.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing Solutions (Manufacturing)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Revenue for the Manufacturing segment was $194.9 million in the fourth quarter of 2024, an increase of 1.6% from $191.9 million in the fourth quarter of 2023.  The impact of foreign currency translation reduced Manufacturing revenue by 0.5%.  Organic revenue increased 2.1%, primarily driven by the Microbial Solutions business.  This was partially offset by lower revenue in the CDMO business.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Primarily as a result of the non-cash goodwill impairment, the Manufacturing segment&#8217;s GAAP operating margin decreased to (93.6)% from 18.5% in the fourth quarter of 2023.  On a non-GAAP basis, the operating margin increased to 28.7% from 25.4% in the fourth quarter of 2023 driven primarily by improved operating leverage from higher revenue in the Microbial Solutions business, as well as the benefit of cost savings associated with restructuring initiatives.</font></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_7"></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Full-Year Results</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For 2024, revenue decreased by 1.9% to $4.05 billion from $4.13 billion in 2023.  Revenue declined by 2.8% on an organic basis.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The GAAP operating margin decreased to 5.6% from 14.9% in 2023, and on a non-GAAP basis, the operating margin decreased to 19.9% from 20.3%.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On a GAAP basis, net income available to common shareholders was $10.3 million in 2024, a decrease of 97.8% from $474.6 million in 2023.  Diluted earnings per share on a GAAP basis in 2024 were $0.20, a decrease of 97.8% from $9.22 in 2023. The GAAP decreases were primarily driven by the non-cash goodwill impairment of $215.0 million, or $4.16 per  share, as well as the loss on certain venture capital and other strategic investments of $0.15 per share in 2024.  This compares to a gain of $1.87 per share on certain venture capital and other strategic investments in 2023.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On a non-GAAP basis, net income was $532.9 million in 2024, a decrease of 2.9% from $548.9 million in 2023.  Diluted earnings per share on a non-GAAP basis in 2024 were $10.32, a decrease of 3.3% from $10.67 in 2023.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Research Models and Services (RMS)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For 2024, RMS revenue was $829.4 million, an increase of 4.7% from $792.3 million in 2023.  Revenue declined by 0.1% on an organic basis. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On a GAAP basis, the RMS segment operating margin decreased to 13.8% in 2024 from 19.5% in 2023.  On a non-GAAP basis, the operating margin increased to 23.7% in 2024 from 23.0% in 2023.</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Discovery and Safety Assessment (DSA)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For 2024, DSA revenue was $2.45 billion, a decrease of 6.3% from $2.62 billion in 2023.  Revenue declined by 6.2% on an organic basis. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On a GAAP basis, the DSA segment operating margin decreased to 18.1% in 2024 from 23.2% in 2023.  On a non-GAAP basis, the operating margin decreased to 25.7% in 2024 from 27.5% in 2023.</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing Solutions (Manufacturing)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For 2024, Manufacturing revenue was $769.3 million, an increase of 6.6% from $721.4 million in 2023.  Organic revenue growth was 6.8%. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On a GAAP basis, the Manufacturing segment operating margin decreased to (9.3)% in 2024 from 12.2% in 2023.  The GAAP operating margin was impacted by the non-cash goodwill impairment.  On a non-GAAP basis, the operating margin increased to 27.4% in 2024 from 21.8% in 2023.</font></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_10"></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Provides 2025 Guidance</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company is providing financial guidance for 2025.  The 2025 revenue outlook assumes relatively stable biopharmaceutical demand trends compared to those experienced during the second half of 2024, including continued budgetary constraints from global biopharmaceutical clients and stable to slightly improved demand from small and mid-sized biotechnology clients.  In addition, we expect that DSA pricing will be a headwind to revenue growth throughout 2025, and that lower commercial revenue in the CDMO business will impact the Manufacturing segment's growth rate.  Earnings per share in 2025 will principally be affected by the lower revenue, partially offset by the benefit of cost savings associated with the Company's restructuring initiatives.  The Company plans to repurchase approximately $350 million in common stock in 2025.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s 2025 guidance for</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> revenue and earnings per share is as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:2.4pt;padding-right:2.4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.128%"><tr><td style="width:1.0%"></td><td style="width:69.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2025 GUIDANCE</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Revenue growth&#47;(decrease), reported</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(7.0)% &#8211; (4.5)%</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Impact of divestitures&#47;(acquisitions), net</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">N&#47;M</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Favorable)&#47;unfavorable impact of foreign exchange</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.0% &#8211; 1.5%</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Revenue growth&#47;(decrease), organic (1)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5.5)% &#8211; (3.5)%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">GAAP EPS estimate</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$4.30 - $4.80</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Acquisition-related amortization and other acquisition- and integration-related costs (2)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#126;$3.50</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Costs associated with restructuring actions (3)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#126;$1.00</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Other items (4)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#126;$0.30</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Non-GAAP EPS estimate</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$9.10 &#8211; $9.60</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Footnotes to Guidance Table&#58;</font></div><div style="margin-bottom:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Organic revenue growth is defined as reported revenue growth adjusted for completed acquisitions and divestitures, as well as foreign currency translation. </font></div><div style="margin-bottom:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) These adjustments include amortization related to intangible assets, as well as the purchase accounting step-up on inventory and certain long-term biological assets. In addition, these adjustments include some costs related to the evaluation and integration of acquisitions and divestitures.</font></div><div style="margin-bottom:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) These adjustments primarily include site consolidation (including site transition costs), severance, impairment, and other costs related to the Company&#8217;s restructuring actions.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4) These items primarily relate to certain third-party legal costs related to investigations by the U.S. government into the NHP supply chain related to our Safety Assessment business.</font></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_13"></div><div><font><br></font></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Webcast</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Charles River has scheduled a live webcast on Wednesday, February 1</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, at 8&#58;30 a.m. ET to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> discuss matters relating to this press release.  To participate, please go to </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ir.criver.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and select the webcast link.  You can also find the associated slide presentation and reconciliations of GAAP financial measures to non-GAAP financial measures on the website.</font></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_16"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Non-GAAP Reconciliations</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company reports non-GAAP results in this press release, which exclude often-one-time charges and other items that are outside of normal operations.  A reconciliation of GAAP to non-GAAP results is provided in the schedules at the end of this press release.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Non-GAAP Financial Measures</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This press release contains non-GAAP financial measures, such as non-GAAP earnings per diluted share, non-GAAP operating income, non-GAAP operating margin, and non-GAAP net income.  Non-GAAP financial measures exclude, but are not limited to, the amortization of intangible assets and the purchase accounting step-up adjustment on inventory and certain long term biological assets, and other charges and adjustments related to our acquisitions and divestitures, including incremental dividends attributable to Noveprim noncontrolling interest holders and the gain on our sale of our Avian Vaccine business&#59; expenses associated with evaluating and integrating acquisitions and divestitures, including advisory fees and certain other transaction-related costs, as well as fair value adjustments associated with contingent consideration&#59; charges, gains, and losses attributable to businesses or properties we plan to close, consolidate, or divest&#59; severance and other costs associated with our restructuring initiatives&#59; the write-off of deferred financing costs and fees related to debt financing&#59; investment gains or losses associated with our venture capital and other strategic equity investments&#59; certain legal costs in our Microbial Solutions business related to environmental litigation and in our Safety Assessment business related to U.S. government investigations into the NHP supply chain&#59; tax effect of all of the aforementioned matters&#59; and adjustments related to the recognition of deferred tax assets expected to be utilized as a result of changes to the our international financing structure and the revaluation of deferred tax liabilities as a result of foreign tax legislation.  This press release also refers to our revenue on both a GAAP and non-GAAP basis&#58; on a non-GAAP basis, we define &#8220;organic revenue growth,&#8221; which we define as reported revenue growth adjusted for foreign currency translation, acquisitions, and divestitures.  We exclude these items from the non-GAAP financial measures because they are outside our normal operations.  There are limitations in using non-GAAP financial measures, as they are not presented in accordance with generally accepted accounting principles, and may be different than non-GAAP financial measures used by other companies.  In particular, we believe that the inclusion of supplementary non-GAAP financial measures in this press release helps investors to gain a meaningful understanding of our core operating results and future prospects without the effect of these often-one-time charges, and is consistent with how management measures and forecasts the Company's performance, especially when comparing such results to prior periods or forecasts.  We believe that the financial impact of our acquisitions and divestitures (and in certain cases, the evaluation of such acquisitions and divestitures, whether or not ultimately consummated) is often large relative to our overall financial performance, which can adversely affect the comparability of our </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">results on a period-to-period basis.  In addition, certain activities and their underlying associated costs, such as business acquisitions, generally occur periodically but on an unpredictable basis.  We calculate non-GAAP integration costs to include third-party integration costs incurred post-acquisition.  Presenting revenue on an organic basis allows investors to measure our revenue growth exclusive of acquisitions, divestitures, and foreign currency exchange fluctuations more clearly.  Non-GAAP results also allow investors to compare the Company&#8217;s operations against the financial results of other companies in the industry who similarly provide non-GAAP results.  The non-GAAP financial measures included in this press release are not meant to be considered superior to or a substitute for results of operations presented in accordance with GAAP.  The Company intends to continue to assess the potential value of reporting non-GAAP results consistent with applicable rules and regulations.  Reconciliations of the non-GAAP financial measures used in this press release to the most directly comparable GAAP financial measures are set forth in this press release, and can also be found on the Company&#8217;s website at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ir.criver.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_19"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Caution Concerning Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements may be identified by the use of words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;may,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;outlook,&#8221; and &#8220;project,&#8221; and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters.  These statements also include statements regarding Charles River&#8217;s expectations regarding the availability of Cambodia-sourced NHPs&#59; the impact of the investigations by the U.S. government into the Cambodia NHP supply chain, including but not limited to Charles River&#8217;s ability to cooperate fully with the U.S. government&#59; Charles River&#8217;s ability to effectively manage any Cambodia NHP supply impact&#59; the projected future financial performance of Charles River and our specific businesses, including our expectations with respect to the impact of NHP supply constraints and our ability to gain market share&#59; earnings per share&#59; operating margin&#59; client demand, particularly the future demand for drug discovery and development products and services, including our expectations for future revenue trends&#59; our expectations with respect to pricing of our products and services&#59; our expectations with respect to future tax rates and the impact of such tax rates on our business&#59; our expectations with respect to the impact of acquisitions and divestitures, including the Noveprim acquisition, on the Company, our service offerings, client perception, strategic relationships, revenue, revenue growth rates, revenue growth drivers, and earnings&#59; the development and performance of our services and products, including our investments in our portfolio&#59; market and industry conditions including the outsourcing of services and identification of spending trends by our clients and funding available to them&#59; ability to gain market share and capitalize on business opportunities&#59; the impact of our restructuring initiatives, including annualized savings&#59; the impact of our stock repurchase authorization&#59; and Charles River&#8217;s future performance, including as delineated in our forward-looking guidance, and particularly our expectations with respect to revenue, the impact of foreign exchange, interest rates, enhanced efficiency initiatives.  Forward-looking statements are based on Charles River&#8217;s current expectations and beliefs, and involve a number of risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from those stated or implied by the forward-looking statements.  Those risks and uncertainties include, but are not limited to&#58; NHP supply constraints and the investigations by the U.S. Department of Justice, including the impact </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">on our projected future financial performance, the timing of the resumption of Cambodia NHP imports into the U.S., our ability to manage supply impact, and potential study delays in our Safety Assessment business attributable to NHP supply constraints&#59; changes and uncertainties in the global economy and financial markets&#59; the ability to successfully integrate businesses we acquire, including Noveprim&#59; the timing and magnitude of our share repurchases&#59; negative trends in research and development spending, negative trends in the level of outsourced services, or other cost reduction actions by our clients&#59; the ability to convert backlog to revenue&#59; special interest groups&#59; contaminations&#59; industry trends&#59; new displacement technologies&#59; USDA and FDA regulations&#59; changes in law&#59; continued availability of products and supplies&#59; loss of key personnel&#59; interest rate and foreign currency exchange rate fluctuations&#59; changes in tax regulation and laws&#59; changes in generally accepted accounting principles&#59; disruptions in the global economy caused by geopolitical conflicts&#59; and any changes in business, political, or economic conditions due to the threat of future terrorist activity in the U.S. and other parts of the world, and related U.S. military action overseas.  A further description of these risks, uncertainties, and other matters can be found in the Risk Factors detailed in Charles River's Annual Report on Form 10-K as filed on February 14, 2024, as well as other filings we make with the Securities and Exchange Commission.  Because forward-looking statements involve risks and uncertainties, actual results and events may differ materially from results and events currently expected by Charles River, and Charles River assumes no obligation and expressly disclaims any duty to update information contained in this press release except as required by law.</font></div><div><font><br></font></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_22"></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Charles River</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.criver.com</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"># # #</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Investor Contact&#58;&#160;&#160;&#160;&#160;Media Contact&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Todd Spencer&#160;&#160;&#160;&#160;Amy Cianciaruso</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Corporate Vice President,&#160;&#160;&#160;&#160;Corporate Vice President,</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Investor Relations&#160;&#160;&#160;&#160;Chief Communications Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">781.222.6455&#160;&#160;&#160;&#160;781.222.6168</font></div><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">todd.spencer&#64;crl.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">amy.cianciaruso&#64;crl.com</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_25"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SCHEDULE 1</font></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)</font></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands, except for per share data)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 28, 2024</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 28, 2024</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30, 2023</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811,913&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838,003&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304,138&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440,019&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,636&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,473&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745,851&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689,390&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002,549&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013,476&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,049,989&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,129,409&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services provided (excluding amortization of intangible assets)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621,535&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564,847&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,345,781&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295,983&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold (excluding amortization of intangible assets)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,770&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,544&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,387&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,870&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,708&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,142&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751,003&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747,855&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,223&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,021&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,471&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,440&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167,687)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,922&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,347&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617,261&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,835&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,591&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,575&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,196&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,234)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,544)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126,288)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136,710)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,705)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,737&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,520)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,537&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216,791)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,706&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,114&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581,284&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,044)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,754&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,823&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,914&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,747)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,952&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,291&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,370&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; Net income attributable to noncontrolling interests</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,088&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,746&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) available to Charles River Laboratories International, Inc.</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,495)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,084&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,203&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474,624&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt 0 7.75pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calculation of net income (loss) per share attributable to common shareholders of Charles River Laboratories International, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) available to Charles River Laboratories International, Inc.</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,495)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,084&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,203&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474,624&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; Adjustment of redeemable noncontrolling interest</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,081)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; Incremental dividends attributable to noncontrolling interest holders</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,906&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) available to Charles River Laboratories International, Inc. common shareholders</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215,699)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,084&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,297&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474,624&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.22)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.27&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.22)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.62&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.22&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,138&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,311&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,380&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,227&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,138&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,624&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,628&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,451&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_28"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.587%"><tr><td style="width:1.0%"></td><td style="width:59.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.667%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</font></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SCHEDULE 2</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED BALANCE SHEETS</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands, except per share amounts)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 28, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30, 2023</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,606&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,771&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables and contract assets, net of allowances for credit losses of $18,301 and $25,722, respectively</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720,915&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780,375&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,544&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,259&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,210&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,879&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,796&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,378&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403,071&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,608,662&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604,014&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,639,741&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Venture capital and strategic equity investments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,350&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,811&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,490&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394,029&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,846,608&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,095,045&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723,400&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,051&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,179&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,279&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,233&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,383&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,528,345&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,195,001&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities, Redeemable Noncontrolling Interests and Equity</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,337&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,937&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,418&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,290&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,322&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,820&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,010&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,825&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,014&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,210&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994,101&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055,082&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net and finance leases</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,240,205&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,647,147&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use liabilities</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,789&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,234&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,960&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,349&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,212&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,191&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,020,267&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,536,003&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,126&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,722&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.01 par value&#59; 20,000 shares authorized&#59; no shares issued and outstanding</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.01 par value&#59; 120,000 shares authorized&#59; 51,141 shares issued and outstanding as of December&#160;28, 2024 and 51,338 shares issued and outstanding as of December&#160;30, 2023</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,966,237&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,905,578&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812,100&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,887,218&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost, zero shares as of December&#160;28, 2024 and December&#160;30, 2023</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317,345)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196,427)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Charles River Laboratories International, Inc. equity</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,461,503&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,596,882&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonredeemable noncontrolling interest</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,449&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,394&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,466,952&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,602,276&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests and equity</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,528,345&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,195,001&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_31"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.725%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SCHEDULE 3</font></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Twelve Months Ended</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 28, 2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2023</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows relating to operating activities</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,291&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480,370&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,741&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314,124&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill impairment</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-lived asset impairments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,825&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,911&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,891&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,048&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes </font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,428)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,903)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Write down of inventories</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,992&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,290&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Gain) loss on venture capital and strategic equity investments, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,910&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,827)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for credit losses</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,774&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,225&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on divestitures, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">659&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">961&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,251&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,079&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in assets and liabilities&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade receivables and contract assets, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,612&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,434)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,804&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,301)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,271)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,427)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,604)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,447&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,541&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,743)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contract deposits</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,584&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,564)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets and liabilities, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51,995)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,642&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">734,577&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683,898&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows relating to investing activities</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of businesses and assets, net of cash acquired</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,479)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(194,785)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232,967)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(318,528)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of investments and contributions to venture capital investments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,876)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54,215)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of investments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,687&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,667&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,549&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,294)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(245,086)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(563,155)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows relating to financing activities</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from long-term debt and revolving credit facility</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,081,581&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">776,353&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercises of stock options</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,878&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,597&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on long-term debt, revolving credit facility, and finance lease obligations</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,493,769)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(851,676)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of treasury stock</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(119,175)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,155)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of contingent consideration</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,711)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of additional equity interests, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,000)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,784)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,442)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,145)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(550,927)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85,521)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,474)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,044&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents, and restricted cash</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78,910)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,266&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash, beginning of period</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">284,480&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241,214&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash, cash equivalents, and restricted cash, end of period</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,570&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">284,480&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_34"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SCHEDULE 4</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECONCILIATION OF GAAP TO NON-GAAP</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SELECTED BUSINESS SEGMENT INFORMATION (UNAUDITED)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands, except percentages)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 28, 2024</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 28, 2024</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Research Models and Services</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,257&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,781&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829,377&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792,343&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,770&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,013&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,411&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,666&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization related to acquisitions </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,327&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,359&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,058&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,742&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Acquisition and integration-related adjustments </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,742&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,905&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Site consolidation and impairment charges</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,129&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,021&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-GAAP adjustments to operating income</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,769&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,184&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,414&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,963&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income, excluding non-GAAP adjustments</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,539&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,197&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,825&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,629&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP operating income as a % of revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,762&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,260&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,812&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,570&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,591&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,050&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,134&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,819&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discovery and Safety Assessment</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,349&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625,785&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,451,280&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615,623&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,859&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,288&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442,510&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606,076&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization related to acquisitions </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,301&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,477&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,013&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,457&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Acquisition and integration-related adjustments </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,636&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,133&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,489&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,095&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,739&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,558&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,740&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Site consolidation and impairment charges</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,454&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,804&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,122&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,023&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Third-party legal costs and certain related items </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,634&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,648&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-GAAP adjustments to operating income</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,120&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,267&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,474&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,096&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income, excluding non-GAAP adjustments</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,979&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,555&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629,984&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718,172&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP operating income as a % of revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,857&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,057&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,126&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,719&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,180&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,414&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,356&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,891&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Manufacturing Solutions</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,943&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,910&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769,332&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721,443&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182,552)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,545&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,453)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,329&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) as a % of revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93.6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization related to acquisitions </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,108&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,083&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,471&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,393&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Acquisition and integration-related adjustments </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,417&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,177&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,802&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill impairment </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Site consolidation and impairment charges</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,337&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Third-party legal costs </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,233&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-GAAP adjustments to operating income</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,458&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,225&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,885&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,182&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income, excluding non-GAAP adjustments</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,906&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,770&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,432&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,511&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP operating income as a % of revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,788&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,305&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,964&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,982&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,320&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,185&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,500&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,134&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unallocated Corporate Overhead</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,764)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,924)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(258,121)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231,810)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Acquisition and integration-related adjustments </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,120&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,839&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,422&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,546&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site consolidation and impairment charges</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-GAAP adjustments to operating expense</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,868&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,351&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,824&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,311&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated corporate overhead, excluding non-GAAP adjustments</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,896)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,573)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231,297)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219,499)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002,549&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013,476&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,049,989&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,129,409&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167,687)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,922&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,347&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617,261&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) as a % of revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization related to acquisitions </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,736&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,919&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,542&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,592&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Acquisition and integration-related adjustments </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,902&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,841&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,070&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,715&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,600&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,186&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,611&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill impairment </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Site consolidation and impairment charges</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,228&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,322&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,380&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,659&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Third-party legal costs and certain related items </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,634&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,648&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,620&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-GAAP adjustments to operating income</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,215&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,027&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,597&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,552&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income, excluding non-GAAP adjustments</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,528&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,949&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805,944&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838,813&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP operating income as a % of revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,104&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,514&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,741&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,124&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,616&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,323&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,967&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,528&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles River management believes that supplementary non-GAAP financial measures provide useful information to allow investors to gain a meaningful understanding of our core operating results and future prospects, without the effect of often-one-time charges and other items which are outside our normal operations, consistent with the manner in which management measures and forecasts the Company&#8217;s performance. The supplementary non-GAAP financial measures included are not meant to be considered superior to, or a substitute for results of operations prepared in accordance with U.S. GAAP. The Company intends to continue to assess the potential value of reporting non-GAAP results consistent with applicable rules, regulations and guidance.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization related to acquisitions includes $9.4 million of accelerated amortization of certain client relationships in the Biologics Solutions reporting unit within the Manufacturing Solutions segment. The remaining value of this client relationship is $75.9 million and will be amortized over the remaining useful life of approximately 6 months in fiscal year 2025.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">These adjustments are related to the evaluation and integration of acquisitions and divestitures, and primarily include transaction, advisory, certain third-party integration, certain compensation costs, and related costs&#59; as well as fair value adjustments associated with contingent consideration arrangements.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party legal costs are related to (a) an environmental litigation related to the Microbial Solutions business, which concluded in 2023 and (b) investigations by the U.S. government into the NHP supply chain applicable to our DSA business. Additionally within DSA, a $27 million inventory charge was incurred to write down inventory associated with the Cambodia-sourced non-human primate matter from February 16, 2023.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In December 2024, a triggering event was identified for the Biologics Solutions reporting unit from a loss of key customers, ultimately resulting in a reduction in Biologics Solutions&#8217; long range financial outlook. As a result, the Company recognized a goodwill impairment charge of $215.0 million.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_37"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.485%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.485%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</font></td></tr><tr style="height:15pt"><td colspan="27" style="padding:0 1pt"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SCHEDULE 5</font></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECONCILIATION OF GAAP EARNINGS TO NON-GAAP EARNINGS (UNAUDITED)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands, except per share data)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 28, 2024</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 28, 2024</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30, 2023</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) available to Charles River Laboratories International, Inc. common shareholders</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215,699)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,084&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,297&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474,624&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment of redeemable noncontrolling interest </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,081)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental dividends attributable to noncontrolling interest holders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,906&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments to operating income </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365,993&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,027&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,324&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,552&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Venture capital and strategic equity investment (gains) losses, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,690&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,919)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,519&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,515)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on divestitures </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,372&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of non-GAAP adjustments&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash tax provision related to international financing structure </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,818&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,694&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enacted tax law changes</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,826&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of the remaining non-GAAP adjustments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,122)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,860)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,445)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,789)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Charles River Laboratories International, Inc. common shareholders, excluding non-GAAP adjustments</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,610&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,166&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532,903&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,899&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - Basic</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,138&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,311&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,380&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,227&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options, restricted stock units and performance share units </font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - Diluted</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,357&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,624&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,628&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,451&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share attributable to common shareholders&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.22)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.27&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.22)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.62&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.22&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic, excluding non-GAAP adjustments</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.67&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.72&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted, excluding non-GAAP adjustments</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.66&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.46&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.67&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles River management believes that supplementary non-GAAP financial measures provide useful information to allow investors to gain a meaningful understanding of our core operating results and future prospects, without the effect of often-one-time charges and other items which are outside our normal operations, consistent with the manner in which management measures and forecasts the Company&#8217;s performance. The supplementary non-GAAP financial measures included are not meant to be considered superior to, or a substitute for results of operations prepared in accordance with U.S. GAAP. The Company intends to continue to assess the potential value of reporting non-GAAP results consistent with applicable rules, regulations and guidance.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This amount represents accretion adjustments of the Noveprim redeemable noncontrolling interest.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This amount represents incremental declared and undeclared dividends attributable to Noveprim noncontrolling interest holders who receive preferential dividends for fiscal year 2024.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This amount excludes Non-GAAP adjustments attributable to noncontrolling interest holders.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The amount included in 2024 relates to a loss on the sale of a Safety Assessment site. Adjustments included in 2023 relate to the gain on the sale of our Avian Vaccine business, which was divested in 2022.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font></div></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in 2023 relate to transfer taxes paid in connection with the Noveprim Group acquisition and a final adjustment on the termination of a Canadian pension plan.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font></div></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This amount relates to the recognition of deferred tax assets expected to be utilized as a result of changes to the Company's international financing structure.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font></div></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to Charles River Laboratories International, Inc. per common share excludes the effect of dilution and is computed using basic weighted-average number of shares outstanding for the three month period ended December 28, 2024</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div></div></div><div id="iaa2b8e5ac6c4482ea92a6d62960b5e9e_40"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SCHEDULE 6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECONCILIATION OF GAAP REVENUE GROWTH</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TO NON-GAAP REVENUE GROWTH, ORGANIC (UNAUDITED) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 28, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total CRL</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RMS Segment</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DSA Segment</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MS Segment</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue growth, reported</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Increase) decrease due to foreign exchange</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution from acquisitions </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of divestitures </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP revenue growth, organic </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.8)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.4)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3.5)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 28, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total CRL</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RMS Segment</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DSA Segment</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MS Segment</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue growth, reported</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Increase) decrease due to foreign exchange</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution from acquisitions </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of divestitures </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP revenue growth, organic </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.8)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6.2)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles River management believes that supplementary non-GAAP financial measures provide useful information to allow investors to gain a meaningful understanding of our core operating results and future prospects, without the effect of often-one-time charges and other items which are outside our normal operations, consistent with the manner in which management measures and forecasts the Company&#8217;s performance. The supplementary non-GAAP financial measures included are not meant to be considered superior to, or a substitute for results of operations prepared in accordance with U.S. GAAP. The Company intends to continue to assess the potential value of reporting non-GAAP results consistent with applicable rules, regulations and guidance.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The contribution from acquisitions reflects only completed acquisitions. </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of divestitures relates to the sale of a site within our Safety Assessment business.  </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic revenue growth is defined as reported revenue growth adjusted for acquisitions, divestitures, and foreign exchange.</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>crl-20250219.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2bfcba33-e4d6-4d05-a3ee-de26c6bf2564,g:15641a46-7146-4bba-bb0d-a06ccb9a1577-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:crl="http://www.crl.com/20250219" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.crl.com/20250219">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="crl-20250219_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="crl-20250219_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.crl.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>crl-20250219_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2bfcba33-e4d6-4d05-a3ee-de26c6bf2564,g:15641a46-7146-4bba-bb0d-a06ccb9a1577-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ed23cdf4-3e77-42a4-802a-5d59b9e6cebd_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_09bb3175-7dc4-435a-a306-571e12c8b300_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f12da8af-27a3-4bc8-8144-f2340e3dcbec_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_d86fb306-230d-480d-9e99-aa2d3ed55f33_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_880436c5-2c84-4c81-bfd9-a6e6fa769f28_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_aa192156-3464-4daa-ae12-49f61c764c05_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1b458272-b46e-413b-8934-4913046d845f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9171d2e8-fa9a-433a-b4dc-cddca516776e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_c912bb1e-7e71-4506-88b9-09db2e94e4ed_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_156deba1-ba96-442b-92cb-0dc4def08d60_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_12b0d8c4-7346-4f55-9ada-fe2b67656723_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_e36a76d1-e8ff-411e-829c-cfaf8d1fe4a1_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_cbaa998d-d3dd-43e0-ab1d-eb6ebdef8e06_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_44282e65-c724-477c-b625-ca2508a53df7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_3dffd36b-eb65-443f-b765-fa7ef0b79a3b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d9c99f7d-dd49-4a93-bab9-193cb2828a75_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b8dc0138-dc64-4caf-b93a-e0c3c90a38f8_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_009ffc0d-8cac-454f-b167-e26491364dcd_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_4ee0ef75-3ab0-4f0d-af8a-15bd01eff30e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a33cee98-6723-480d-a05a-97a8ccb728d2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_324aa6c9-61cb-4048-92e0-a810b36015c1_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_608aee2d-32eb-4df1-82bb-19d54d7ba9d4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_3557b015-7762-49ef-b84c-b0e7d7d37902_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>crl-20250219_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2bfcba33-e4d6-4d05-a3ee-de26c6bf2564,g:15641a46-7146-4bba-bb0d-a06ccb9a1577-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.crl.com/role/CoverPage" xlink:type="simple" xlink:href="crl-20250219.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.crl.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cfd9515c-3c18-4323-bf4b-749b1515ad68" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_DocumentType_cfd9515c-3c18-4323-bf4b-749b1515ad68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4845b7a2-37e9-40af-ae81-9ae6e9a508a8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_DocumentPeriodEndDate_4845b7a2-37e9-40af-ae81-9ae6e9a508a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_31936b9d-2c1f-4ef8-9231-900da60ebc5a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_EntityRegistrantName_31936b9d-2c1f-4ef8-9231-900da60ebc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_73a635da-4c9a-4c1e-ad06-12e520c1ac69" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_EntityIncorporationStateCountryCode_73a635da-4c9a-4c1e-ad06-12e520c1ac69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b7994c19-4f7a-4fd1-bf23-08e0b60a348e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_EntityFileNumber_b7994c19-4f7a-4fd1-bf23-08e0b60a348e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_357331b7-120d-4ffe-8ca4-2e7817cf7c0f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_EntityTaxIdentificationNumber_357331b7-120d-4ffe-8ca4-2e7817cf7c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_db033ada-70d0-4042-a49b-a005df42028f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_EntityAddressAddressLine1_db033ada-70d0-4042-a49b-a005df42028f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8d546c8d-7056-4c74-8b84-00ee9a930208" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_EntityAddressCityOrTown_8d546c8d-7056-4c74-8b84-00ee9a930208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5006b347-0c9d-4e1e-8b28-725998800ff3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_EntityAddressStateOrProvince_5006b347-0c9d-4e1e-8b28-725998800ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e98f6fc0-4a34-4294-a9ed-43fb64efcda4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_EntityAddressPostalZipCode_e98f6fc0-4a34-4294-a9ed-43fb64efcda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_52ededb5-17e1-4847-9842-f54cb2fc983f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_CityAreaCode_52ededb5-17e1-4847-9842-f54cb2fc983f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6d2cb480-efc2-4295-b7a1-aee0df55f8d5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_LocalPhoneNumber_6d2cb480-efc2-4295-b7a1-aee0df55f8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d884310b-0e0b-4372-b052-fbb1ffc61b52" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_Security12bTitle_d884310b-0e0b-4372-b052-fbb1ffc61b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_10cf530c-c8dd-4076-84ac-9c11c9d59593" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_TradingSymbol_10cf530c-c8dd-4076-84ac-9c11c9d59593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b6ccb2a4-9a6d-4223-a8c0-36df84f09d30" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_SecurityExchangeName_b6ccb2a4-9a6d-4223-a8c0-36df84f09d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_999c52d7-fa4a-4f55-b25b-1e15af0703e3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_WrittenCommunications_999c52d7-fa4a-4f55-b25b-1e15af0703e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_124a5729-bc64-4ef4-8f33-7249d6ec3576" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_SolicitingMaterial_124a5729-bc64-4ef4-8f33-7249d6ec3576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_8e7ced4a-15c4-40c3-bd15-6f733ad8f76f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_PreCommencementTenderOffer_8e7ced4a-15c4-40c3-bd15-6f733ad8f76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_fe20c64a-a1cb-49a7-90b8-cd610d7166cf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_fe20c64a-a1cb-49a7-90b8-cd610d7166cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3e623b3c-5c06-4a6c-ace0-7746a1c0baf6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_EntityEmergingGrowthCompany_3e623b3c-5c06-4a6c-ace0-7746a1c0baf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b9b8f034-bf2f-49cb-a45b-ddebd4f6fdb6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_EntityCentralIndexKey_b9b8f034-bf2f-49cb-a45b-ddebd4f6fdb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_bad4fbc2-91c6-4118-b996-def9622271e0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_046a9dd1-7824-452f-8e4d-574b08802334" xlink:to="loc_dei_AmendmentFlag_bad4fbc2-91c6-4118-b996-def9622271e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0a.jpg
<DESCRIPTION>CRL LOGO
<TEXT>
begin 644 image_0a.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" $T!)<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH "<#--WJ>QIQ&>#3=J^M*R#0,(>^*-BCJ:4!3T[4$#&#1S"<4PW*O I0
M<C-)L7K2@8&*-P5D%%%%,84444 %%%% !1110 4444 %%%%  1D8INP^HIU,
MW,.])NP#E4@Y-+113T8KA12-N["E'3FIY4G<84444T[BL@I&4DYS2T4QA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M1D$-DL"/2I*3:/2@32N,W*<9/6O+OVDOV5OA;^TIX0N?#/CS0(YS)&PBE "E
M6Q@'.,UZIY:8QM%-=0/I6V&Q6(PE=5:,N5HPQ.&I8JDZ<U=,_G__ &^O^"0'
MQ0^ /B*[UKX?:1+J6C;V:,6L)(11[G%?$VL:)JOA^]>PU&R>VEC8J\4@YR*_
MK%\4>#_#WBVQ;3?$&EPW4#KATE3((KX[_:M_X(P_L_?'>">^T:!M(O')=6L;
M91N;T))]:_=.&/%GV4(T,QC?IS'Y/G? ";E5PKMY'\^8<?\ +1B3_O4 ,!DN
MV#ZM7Z ?'3_@@+^TQX.N[B^^'EI;7]BC$QO<WP5R/H :^</&/_!//]IOP5,]
MKJO@69WC8[O(1W'Z+7Z_@.+^&<=&\:T3\^Q/#N<X=V<&>';<C*M@CUH.%X?)
M)]Z](3]DSX\R7'V=?A[J'7J;.4?^RUT_A/\ X)Y_M->,;I;;2? LP9NGGHZ#
M]5KTY<19+15W7BEZG"LFS6H_X3/$%C !4G ]Z1%D?Y50@=C7W3\)?^"#O[77
MC>>*?Q)HUE:6<A!:1=0&X#Z$5]J?LX?\$ OA/X!$&J>/]:NK^X7#26T\2/'G
MKUS7RN;^)'#67)\E13?9,]O+^#LZQ<K2@XKS/R#^$7[,'Q@^,VHQ:?X/\'WM
MPDS#%Q''E1^M?HW^Q=_P0-O]>EM/%OQWGC$&0SZ>\3(Y'UY'(K].OA)^R;\$
MO@]91VGA;P980,@&&2 *>/QKTR&%(4$,8 4# QV%?CO$GBOF.81=' KDB^O4
M_2<EX P6%:J8GWF>>?!/]E[X1_ ;PY;^'/ 'A2&VAMT"H616; ]\9KT-8HTP
M(T"@=@*<'1>-QIQ8%=RKGZU^1XG$XK%5'.K)MOJS]#H83#X:"C"-D-W!^@QB
ME!VCW-(#P<J!GTI[#N!S66ZLS=OL(N[.#TI2HQ@"AB,8)Q2*Q)VCGUJ5=;##
M9CDTT@=:#)N;CM2!PQVK^)JG>P:WT"2(2H8Y%&".0:^9?V\/^";_ ,*OVN_!
M-TESI4-OKD<;&PO<8$<AXR0HR>,U],R3I&N^1U51U+'%>>_%[]J#X/\ P5T:
M?6O''BNWACMT+.B3(S$#T&[FO6R>OFE#%QJ8*_/?H>7FM'+L10E'%6M8_GD_
M:S_X)Z?&G]F/Q%<V^K^&[FZL(W.R]B@VH1G@\FOGXI+$[))\K= #VK]6O^"A
M/_!9?X*_$?3KSP'\._!UEK*2(T;7&HVK*4.,9'4=\U^5^OZI'J^KS:FMLL(D
M<MY<8^5:_KS@S,,WQ^ 7]I4N67F?SGQ%A\OPF+<<%.Z\BH;FY5P!*X]<,:#+
M,),B5S]6S3 V/F?H>]*,9V;N#T-?8QI4UHXG@<]6V[ MC+ <^E"AMA8N!_LX
MYHZG'''?O2^6\IV11,S>PJTX4EKL0I2;&[6"_>QS]W%!P0'89] *L#3KXC#6
M-QST(A)KZ[_X)O\ P>_9&^(7B>WTOXU^*;ZTU(R*%MI;-?(9N,@LS#BO*S;-
MZ>68259+FMT6K._+\!+&UU!NUSYV^%7[.OQ7^,MY%:>#?"%Y<B1PH:*,,.OU
MK]%OV'/^"#>K^)9+;Q;\>G6.U4J[:=+$R.1Z9&17Z5?L[_LU?LV>"-"M9_AQ
MX>TF11$I2:%$R>!SP37L\-O#;1B*&,*H["OYUXG\5\TQJE0PJ<%Y[G[%D/ 6
M$H156L^9GG7P0_9=^$7P&T"#0O OA6&".) -Q168G'/.*]&140;43:!VQ3EP
MJX;\*7:3VZU^0UL56Q4W4JR;;ZL_2<-A:&&I\D(V0P,5&5!/-/0L.6[]L4!6
M7H,4JY*D URI-=3?2]D.()&,T@3!SFDP_O\ G02,8W&JW!NP?(>^*" 0.<"D
M!3J,_0TC,=V#2?*M 5V2 @C-,QEB/7O223P(N^20(J]2QP*\V^,7[5OP:^!^
MES:QXY\6V\20J<I%*C-W[;LUOA\)B\745.A!R;Z)7,*^(P^'CSU9)+S/2)-B
M'<#6'XK^(_@OP=;FY\2>(K>S15R3,Q%?ES^U_P#\'!6B6TESX;_9]L$O0,HU
MQ>1O$5]P1GN*_/GXR?\ !1?]HOXR7LTNH^-KZ"*4DM%%=-M7V&17Z;D/A7G>
M9I3Q'[M>>Y\+FW'V7X1N%)<WH?O'X\_X*3_LQ?#^9XM0^)&FLRG&!<8Y_*O-
M-4_X+;?LL6-P;>/Q-:R8.-RW8_PK\ -7\;^+=>D:XUCQ!<W))R3+)FLMO-G.
M]CQW)-?H^%\',LC22KR;EZGQE;Q%Q?-^ZT1_1/X6_P""R?[*GB*9('\:V,1<
MX^>[_P#K5[3\./VR?@/\2PJ^'OB#ITKO]U%F))_2OY<[2\GLY-]E<.K#OG!%
M==X,^/?Q6\ WB7/ACQG?PE3G"3[<5SX_P8P4Z=\/+E?WFN&\2,9&:56-T?U6
MVNH6.H0+=V<XD1AD,IX-600PR*_ O]E#_@M_\</@[>PZ5XZ*ZI8(0&ENKAW8
M#Z 5^L/[)'_!2OX"_M2Z#!)H'B1(+\H/.@N (L/CD#<>:_(.(.!<ZR&;E./-
M#NC]%RCBW+LSC:_+(^DZ*K6EW#>PBX@D5D/(93D&IXV4C -?&M6=CZB$^=76
MPZBFY!/4T*<-@FE=%CJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@35PI#QR!2T$9[T#&'=]YFP/0TUE8KD$8
MS4A0'KD_6D*X.1^5+GLA<JN136\$R[)858=PPJC<>$_#TYS-HEHV>[VRG^E:
MA&1]WFF[6'.*J%5K9F4Z%.>Z,/\ X5YX.,OG'PU8;L]K1/\ "K=OX5\.6XW0
MZ'9H1_=ME']*T1G.0* C>E4ZU>3UD3'"X>'V2.*VMXEV1PHH'95 J0;6&-F!
M1M!.!Q2A=N>>,5G-2EU-DXIV6QY/^U9XF^(_@7P2_C/X=PR7$]B@+VL*99QD
MDXR1V%>0_L[_ /!5/X)?$B^/A'Q]K4'A_68G,3V]_<#<[@[> H/4@U]6ZII=
MIJUC)87L*O'*A5@PX((Q7Y3_ /!6/_@F3K^F75U\<O@9#);7$.99TM/E(VC)
M( R2<FOK^&\-E.:OZGB7RR>TCYG/:F88!_6,/[RZH_4[1/$VB^(K%-0T6_CG
MAD4&.5#D,/45HHP*[<YSWK^;[X'?\%//VK?V;=7&CZCXBO=1CM7V/:ZG<N-F
M.V,5]M_ S_@X5TEK6*R^)NE1PRG +01._->]F/ACGN%C[2A:<>AY&"XZP-5\
MF(]V1^L_S#H/R%+ECU''TKXN\!?\%I/V8?$Z1-J/B"6#>N3_ */C'YFN^M_^
M"IO[)LZ;QXW;IWC7_P"*KY"MPUG6'GRRH2^2N?1T^(LJJK2:/I,X PW([4UF
M (&.M?*WBS_@KG^RCX?M6FB\6R2,!T$(/\FKPGXN?\%^/@YX?MY[;PDK7,RJ
M=ADMF S]16^#X-XAS"=H46O70RQ'$V3X:-Y5#]')IH(1^\E (&>:\L^-?[9/
MP%^!6ESW?C;X@Z=;7$*DK;2S%6<CL.*_&?\ :%_X+K_'KXDV]QHW@V"+3XI,
MJMS;SNC@?E7QMX_^./Q8^*%\]]XX\<ZAJ#NQ8+<SE@*_1LB\'<?B:BEC9<J\
MCXS-_$?"T8N.$5V?J#^V/_P7O+RS^&_@M;2H""HNUE1U/;/8U^;WQV_:T^,G
MQ]U:2_\ '/BJ>:-F+!$<J.?H:\U9A+\Q.6]Q344'@<_6OV_(^"<FR.FE1IIR
M75[GYAF'$F9YG)NI-I=@9F7YW8L6/0G)I27#E V0_P![CI2."!@H22V!@<UZ
ME\ OV1?C+^T+K,6E^"?"\[K(P!FEC9%Y_P!K&*^@Q>.P>7T^:K)*QY6%PM;%
MSM3BVSRV.-W4K&X89^X.IKM/AE^SO\9/C'<QV7P]\!7^I.YP!;1@X_6OU6_8
MR_X(*Z+IIM?$WQIF?S  QMDVR*3UP>E?HC\)OV4_@E\'+*&V\&^ =-M7B 'G
MQ6P5FQWXK\CXB\7L%@6Z6"7/+\#[[*. ,;C+2Q'NQ/QB^ 7_  0=^._CZ*WU
MKQI=?V7&^-]I=6C;A^(KZ_\ A=_P;\_"#188[CQ5<P7,N 7VEQ_,5^DD-O;P
MJ$AA50.F!4FT#G?7Y'F7B3Q'CYMQGR+R/T;!<#Y/A8I2CS/S/C"Q_P""+/[,
M%I:BW;P[&S!<%O,/^%<E\0_^"&'P+U> W?A+%A<("8Y$F<$'\!7WVP"G ';O
M28&T+C@5XBXOX@D]:S:/3EPSE"7NTTF?E3>W_P"V?_P3BU-9KMKSQ%X7BEP#
M:V^ D>>[.W85]<?LE_\ !3OX"?M&:9%8W?BFTTO5R &TZYN,R%CVX&*]_P#B
M)\-O"WQ*\-7'AKQ1I4-S!<1,A65-V,C&:_%'_@I[^P%\3?V2OB)-\6_@C<7E
MKID\KS*]B<&,#@<*#CI7T65+*N+9_5L5:G5Z274\+'/,>'YJK3;G3[/H?N)8
MZG8ZG"MQ;2AT8 J5/4>M6RP8 KUK^>W]FG_@M#^T;\%IXM'\4W;:I;0MMDDO
M[ARX .,8Q7W/\&_^#@#X1^)HX;3QC&UK+@!S';,1^9J,S\-.(,#K3BIQ[HZ,
M%QMEF)]V;M(_2H#/)I0."#Q7RWX,_P""LO[*OBBW4MXN>.1AG:\0'\VKI!_P
M4C_9@()_X3=2 >?N?_%5\A4X>SB$[.C*_HSWXY[EG+_$5O4^@NHIA^7JN:^9
M_$O_  56_92\/6S22>,G9E'18U/_ +-7@OQ>_P""]_P1\)I-!X7=KJ0 A-]J
MV#^1KNP7"6?XZ?+2HOYZ&%?B+*</#FE-'Z'SSPP(9)& P.F:\I^-_P"V;\!_
M@1I4]YXV^(.G6MQ$IVVDLQ#M[=*_&_\ :/\ ^"['QV^(XN-&\"0Q6%M)D+=0
M3.C@'\*^,OB/\=?BM\5M0>_\;^-;^_9SDK<SE@*_2,C\'<=7FIX^7+'LMSXC
M-/$;#T[QPBNS]./VP_\ @O=<78N?#OP7MIHC\RBX657!]^H]*_-WXT_M1_%_
MX]:S+JOC3Q5<2AV)\I791U]C7GDC>8_FJ<YX9C2#:AVL< ]QUK]LR/@W)LA2
M5.FKKK;4_,\RXCS/-;NI.R["M('.3DY/S9/--7@D>62O;%+&K$\)D]P!R:]-
M^!'[)7QD^/VM1:=X(\+W+Q2N TTT3HH_'&*^CQN-PN7T?:5)I)'CX?#U\74Y
M::;9YBN%7E"7'6ND\$?"#XE?$BZ6V\$^#;W4I'. ELH)_G7ZM_LA?\$"].BA
MMM?^--Y*KX5O(C*R!CZ'.*_0GX/_ +%'[/OP8TZ&P\-?#S3!-$H_TDV@#DCO
MD5^2\0^+N5X-N.#7//\ #[S[[)_#[&XRTZ_NH_"WX-_\$<_VKOBJL$VJ^#;[
M1(Y,?->6F0!^!KZ2\"?\&\GC0PH?%7C"TEW8W*MLZD5^RUII5C91""VMDC5>
MBJ.!4HCC'W5%?F./\6>(<3\%HKR/N\'P!EU"UW<_+'2/^#=WP.D*I?ZU;L2.
M6Q(,?I78?#C_ ((=6/PDUR+7?!GC-;>XBD#*4>7'!STK]("!MZ?2DP,YQ7S.
M)XUS[&0<:U2Z?0]JCPOE>&FG"-F<9\%O"7BOP=X2A\.^*=66\DAC"^:J$?SK
MLXPH'##BE11R,=: FTX''O7RM2M[>;EW/HZ4/94U'H&T'E?RI5SGD?C2A5!R
M#2U&A5M= HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%( VXDF@!:*** "@@'K112?<5[A2;<'.:6@CN#2Y5+5C
M"D96)ZTF']_SI5#=ZI:":N'"CI28+-D4K#(P*0*0O7FIM*^X*R0.I/-9VM:'
MIGB/3IM+U>V26"9"KQNH.15\QN:5H@V/:B/-1J*47J2U&K!QDC\K?^"FW_!%
MK2_%DU_\5_@;8K#>S%IKJTCC+&1CW P .!7Y)_$SX2^./A+KTNB>,-#N+.>&
M0J1,N,X)_P *_J[NK2WNX3%=1!E8892,@U\V_M7?\$U/@7^TII\[W^@06=Y(
MIQ/;6Z[LX]2:_9>$/$ZOEL8X?'^]%;/_ #/S7B'@>&*;K8;1]C^;47]\J_+>
M2[2>BR$8J4:]JT8VIJ-RO89G;_&OT!_:G_X(+?'GX>W=SK/PE@AU#3 2S&YN
MPKCT 4 ]LU\<>,_V6/CAX%O7L->\!:B'C8JS1V4K+^>VOW;+^)N&<UI*I"I%
MM]-#\JQ>39Q@YN$H2L<%-JNK3?+)J<[#WE/^-12R3DYE=F'N:UY_A]XVMIC%
M<>&+]&'8VDG^%,3P+XP<A5\.WQ)[?9'_ ,*]^GBLL<>:-OP/+=+%N7*TS'39
MR5X-+EV^7E3V8UU>F?!#XIZU-'#I_@?4Y"Y 4I82D?HM>W?!W_@D_P#M=_&.
M>-M"\&Q0Q'!+7LK1$ _[RUQXCB#),'%NK52MYG11R?,:[]RDV?,V))/D4;C[
M5VGPO^ WQ/\ BYJL&E>"?#%U=M,X4&% <9_&OU-_9<_X-[K'1FM]<^,^L3+=
M##/:P2))'[CK7Z _ _\ 8B^!7P0T^*V\,^"K$SQ*,7#6P#9]>*_-,]\7,LP*
ME3PGOONMC[3*^ ,=C6I8CW4?F9^Q#_P06USQ+):^,/CM,D5N&#_V?/"R.>_4
M9%?J=\$/V6?A!\!?#T'ASP)X6AMXH4"@E0Q_/%>B6]G';1+#!&%51A5'05(J
M-U)K\&S[BW.,_K.5>H[=EL?J^4<-9=E5-*G'4:D,4<?EQ( !V HP%Z\?6G&(
MM_$1]*4JQ.& ([9KY9S:9]%#16$ R,Y_"DP?2GE3C@<^U)A_?\Z'S/9V#E0F
M>,$4@&?XJ>%)7YNM-V-Z4+F07:=@9<#K^%<I\5?A/X.^+OA6Y\*^+M*2YM[B
M,JZN!Q^E=8_WJ39CDC%:TJU2C-3@[-&56A3K0<9*]S\-_P#@I5_P1L\7?"76
M+WXA?!_3VO-*8F66VMH22F?F.2<>M?G=JVF:IH%^UAJ,$EM<(<-$QP5/X5_6
M3XB\,Z-XHTV32M:L([B"5"KQ2KD$&OAK]M/_ ((J_"7XZ+<:YX#LUTW4) S*
MEM&J*6/OFOW/@[Q0C0IQPV9Z_P!Y_J?D_$? 52<WB,'IY'X,V^M:Q =T>J3J
MPY $Q']:LCQ?XF$?&NW S][]\W^-?2W[1_\ P21_:G^ .J3R7/A5+NP4GRI;
M64S.1VR%'IBOG?6_A5\0O#\S0:MX0U&(J>=]E(/YK7[;@,XX=Q]-5*$HMOT/
MS7$Y?F^$;C--(R[G7M9N%!FUB=B>WG-_C5:22XGPTTCM[LQ-33:/K43;6T:X
M'L8&_P *5-%UJ<@Q:7='V\AO\*]A2P*CS*WX'F2^MR?*VRHVT'Y)!FE+%B!(
MM;NC_#3Q[K<@ATOP??S,QXV64A_D*]?^#/\ P39_:F^-U]':^%_ [Q;V )OP
M\(Q]66O/KY_E&#O[:JE;S.JAE&85W^[IMG@@9MQ.<H177?#'X%?$KXLZK'I?
M@?PI=WSRL &@0$#]:_3?]F'_ (-Z=9BEM]:^.6HM!(I#-;6DZRH?;M7Z)_ #
M]A+X%? 738;;PYX1LWFB4#SWM@&)'T-?F^?^+F5X.+AA/?ETML?9Y1X?X_%3
M4JWNH_,W]A3_ ((.^(?%MU:>-?CNZP6RE7?3KB%D=AW&1D=Z_5/X(_LM_!_X
M%:#%H?@7PQ! D*!<[0QX'KBO1[>R@M(A%;1A%4<*HIXC"J0JC)ZU^!Y]QAG'
M$%9RKU'R]EL?K64\,99E,%R03?<CMTC10L,84#H *D) .0.?6FK$R+]/>G[2
M1SUKYAN[/HK12]U6$4_/DGKTI6!)Z4NT<<=*6IUN/9" 8&#1@9S2G..#28R>
M:EV<K,89Z^U- W=Z>!BDVC! [T/G4M!63$51GDBE4G)!%($.>:4%L\BG).3$
MDHZ"T445104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%&1ZT %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%&1TS0 449'K10 4444 %%%% !1110 4444 %%%% !1110 V0';
MD#--/!#!=V>..U/8@#FF@.J82ANR%J175E;W*F*>W$BGJ&4$5SGB3X/?#OQ9
M&T>L^%K20,.3Y"Y_E73AF8[3GWI?E]3^5:4*^(HRYH2:]#*I0P]56J13/%-6
M_P""?_[,>LW37E[X!A:1B2<$#^E58?\ @G9^RU:2B2/X=Q[L]=P_PKW0ID9/
MX48*@#.?<UZ/]NYNM%B)_>S@EDV6-W5)7]#S_P (_LR?!WP0%/A_P7:H5Z;H
ME;'Z5VMIHFD:<H6TTN"/':.(+C\A5P %@0QH*G.">M<5?%XK$RYJM1M^;.NC
M@\-0^&"0*L:X; SVI5!WEL]>U 3 ZY^M R6^>N1R:9U6[#J***L HHHH ***
M* "BBB@ R!U--8Y''2E<$CBFH"3[5+3W0:6$&.XH;J<'(]* #G%*ZC(&3TI^
M[(F-^I2U+0-&UB,PZCI\$H88(DC#?S%>:^.OV*OV??B-*UQXG\#V\S'.2BA>
MOT%>J@#KCFE!([UU8?&X[!RO2J./H['+6P6!KOWX)GRYK?\ P2,_9!U.4W$/
M@!(F)R29?_L:71_^"1O[(6GNLT_@6.0@\8E_^M7U*"'!!%(4QR/RKTUQ-GRA
MRK$2MZLXWD&3MW]BON/(/!/[#W[.OP^G63PYX#@C*8VLX#?TKTW3/"OAW1HU
MBTW1[:$*,#RX%'\A6@3N.23^%(48MGMVKS<1F&,Q+O6J.7JVSLI8'"X?2E!(
MD"HB@ # Z4HY&: .,&BN7<ZTK!1110,**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** (K__ (\9_P#KBW\C7\AO_!R5\O\ P4<UIAU.EV__ +-7]>5__P >,_\
MUQ;^1K^0W_@Y,_Y2-:S_ -@NW_\ 9J ///\ @A&2/^"E7@8^\O\ [+7]EGAE
M0/#>GC'_ "Y1?^@"OXT_^"$G_*2KP/\ 67_V6O[+?#/_ "+FG_\ 7C%_Z *
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MVA/CMKEUK'CKXE:M<)=,2]L]ZS(/8 UYGY&H:E(95ADD8GDA22: /Z3?$?\
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M9=V* %HHHH 3>OK^- 8DXVU7U/4M/TBQEU#5+N*"&%2[R22!0 !DG)K\P/\
M@JS_ ,'$/P5_9"-_\.?AQJD6J:\H:,- GFQJXZ?.A- 'Z7^)OB#X0\&V[77B
M;6X;.-!EGE/%>$_%/_@J[^PS\'Y9(/''Q^T*Q>/.1/.P_P#9:_EC_:P_X+=_
MM@_M):S=NWCB]TNSED;RTL;UT^7/'&*^5/$_Q<^)_C:5G\4^-]2U L>3<W!<
MG\Z /ZV/%_\ P<=?\$W_  U(T=E\<M!O67M%>D9_-:Y"3_@Y]_8&23:/&6FE
M?[WV_P#^M7\G/V74;E]XLYG)'4QDTY-"UR4?)I%TP'<6['^E ']<'AW_ (.5
M_P#@G9J\RQ:E\6M&L@?XI;X\?D*]<^'/_!;+_@G?\3)(X/#W[1WAV623&$2Y
M8G_T&OXPFTS5HB3)IEP#C^*%A_2KNB^*_%OA>02Z1K-[9.I^4PN5Q0!_=GX"
M^/WPF^)=LEUX,\:6=^D@!1H')S^E=CN!&1T/>OXCOV>_^"G'[6/[/NNVVJ>'
M?BEJUU# X/V>YOWVX!Z8K]R_^"0?_!R=X8^.&H:?\(_V@KN&QU&;;%'=,I"$
MX&27? ZF@#]IMP!()Z"A6##(Z=JH:#KND>)=&@UO0[^*ZM[F)9(I89 ZD, 1
MR#[U>B)* ,,$=<4 .H)P,T4'@9- &#XU^)G@CX=PQW/C/Q!!I\<K;8WG8@,?
M2N=7]J;X!R2+%'\2].9FZ .?\*_(W_@\'^+'Q)^&'P4\!WG@#QOJ.CR3^)I4
ME>PN3&6'DJ<'%?@=X;_:Y_:;_MVQBD^./B0J]W'DC4G)^\* /[E="\1Z-XET
MY-6T2_2XMI#A)8SP:76_$&D^';&34M9O$MX8AEY'/ %?%_\ P21^.-AX/_X)
M@Z%\5OBSXO#K9F>6ZN[^Z&]E41]-Q&3S7Y!?\%H?^#BKQY\4/&6J?"']GK5G
MM-,M)7MWO86:-WP>"".#P: /V5_:G_X+>?L-?LN)/9^(_B[H]SJ4.1_9XNBK
MDCMR*^)_&W_!XQ^SEX9U22QT;X%WNJ1*Q"3P:K& P]>37\X/CKXC^-_B7JDF
MM>-/$5WJ,\KEB]Q*7.3_ /KK'6RNP!BUD8$<%4)H _IP^$O_  =Z?LM>/=3B
MLO%WPOF\.12. T][JB$*/7@FOT+_ &//^"BG[,_[;6F?;/@C\1-.U:95_?6]
MG,69"!D@\=J_B#:TO$&9;68'MF,U^Y/_  9X:AJ2_%'5+26=S"1<GRR>,^6>
MU ']!OQ(<-X'U$=_LY_F*_B3_P""C_\ R>=\0/\ L9[O_P!#K^VKXD _\(1J
M!88/V<]/K7\2O_!1_P#Y/.^('_8SW?\ Z'02MSZY_P"#8C_D_P#T'_L*P?R-
M?UGP?ZE?]VOY,/\ @V(_Y/\ ]!_["L'\C7]9\'^I7_=H*'4C,%^\:6D..A^M
M "@Y&:;Y@ .X8/I2,R@9#$?TKPS]MG]OGX%?L4?#:Y\;_$KQ;:QS)&1!9Q3H
M\K/MR,IG./PH ]MOM7L=+MC=ZC.(8U&79N@KP;X[?\%.OV-?V>?-3XD?&S1M
M/DB7E+B9@<^G2OY\O^"C'_!R_P#'#X\:W?\ AGX+W1TW3&=EBGA9X7VGH>E?
MF-\1_P!H#XO_ !6OYK[QQX^U/46FD+LMU=,X&3G S0!_3_\ &7_@ZC_8B^'%
MS)!X0N+7Q($)PUEJ(&[\\5XMJG_!YK\!+&X:&U_9NU*X4'ATU:+!_6OYO8;#
M4KD[[>QFD)_N1$_RJY!X*\9SKOM_"&IR ]TL)"/T6@#^D/PQ_P 'D?[.^MW
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M]KQ?XU_.K:^!/'=^FRQ\%ZK/GHT.G2M_):M#X4?%%%,DGPW\0>Q_L>?'_H%
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M\$Y?&UJ]KK/P(MFR, B;']*^2OVJ/^#5K]E?XB6%S??!^UL]!F"$Q1%'<Y_
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M]M^U=^R!;Z%J6H(VJ:%*MD(6;#,D:$%L'GMUH _2/()P#^%+36_O+3@01D4
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M^9H Z*BBB@#\+/\ @]&.?@3\/<?]#7+_ .B%K^==%+L$ R2< 5_1/_P>C?\
M)#/AZ/\ J:I?_1"U_/'X?B6?7+.!QD/<Q@_BPH _:[_@UE_X)T1_$/QK-^T+
MXTT#=:VL226+S1Y&]'YP?H:_HZLK2*RM$L[90B1KA !T%?#G_!O=\-?#O@[_
M ()T^%]2TRR2.>>YG\V14 +#Y#@U]U#G!% "CIUHHHH **** ,/XE?\ (CZC
M_P!>Y_G7\2/_  4?_P"3SOB!_P!C/=_^AU_;=\2O^1'U'_KW/\Z_B1_X*/\
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MBL$0C7 P"<?SK\"/^#13X7^'-0\:ZOXXN[.,W1LBJR%1GY9#BOZ*DY/3CM0
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MI^_DC '>J'_"8>$O^AHT[_P-3_&D/C#PB>#XGT[_ ,#4_P : +_#-NW96DP
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MOAAH]N8XCM9+!%(]^*_E6_X.#+2TL?\ @H'XQM[.V2*-=:F"HBX X% 'E?\
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M\#/%JSQY)C_M7540^W>@#\6?!/[4'QO^']P+CPMX^O;9E.5/G,?ZU[E\,_\
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MW_\ 1AK^@=<Y(S0 M%%% !1110 5_-%_P=K_ /)=-*_Z\'_]&K7]+M?S1?\
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M ->OTS_X@W_&7_0VQ_\ @V3_ !H/_!G!XR''_"6)S_U%D_QH _,J\_X+5_\
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MHDUC2'2<3+'EO*B&\C]*_2^N<^+'@;3OB+X U7PEJ=LDL=[830[77(^9"O\
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MQ=IL*Q\DR7J+_,T ;A.5RP[\52U[6]+\,Z9-K6LW:P00H6DE;HH%?-O[3?\
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M!?9BS848;/3U%>,_M]?'7P[^SO\ LN>*/B9XEU!+>'3M/,NV1L9P:P_VF/\
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M4_6@!:*** "BBB@ K^:+_@[7_P"2Z:5_UX/_ .C5K^EVOYHO^#M?_DNFE?\
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M?./[</\ P74_8U_8Z\*W=[JGC%-4U 1,L$&DR)<$.00,A"3C.*_G/_X*C?\
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M!_X;TT;C^!?_ $,5_8KHG_((A_ZYB@"XO0?2BA>@^E% !1110 4444 %%%%
M!1110 4444 %%%%  0&&#WJ&ZB@N(6M;F,&-U*LI[@U*Q"KN/:HU#ELMC:>>
M>M 'YB?\%FO^"#OP_P#VT_#&H?$/X::1#9^*$B>2,PV^YY'Q@=O>OYIOVL_V
M)_CK^R!XZN?!WQ5\%7>G>3*RQ37";?-4' 8?6O[EF5-I5UR#U!%>*?M._L#?
MLX_M7>'+G0?B7\/M.EEGC(6]6R0RKP>C$9H _A]TG5M4T>Z%_I=S)$\9R&1B
M,5]#?!'_ (*I?MC_  ,$4'A'XL7\%M$ JQ*W0>G6OV"_;0_X-+M.U.^NM=^
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M15 Z# [5<1W*G(&X=30 \<\D4M-#$MMQVZTZ@ HHHH *3.&QN_"EI#@'<>U
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M/P1:L&@T"!2.A""M:VTK3K-0MO9QJ!TP@JQ10 BQQJ<J@'T%*  <@444 (%
M& * JA=H'%+10  !1@"BBB@ HHHH *0J#U%+10 8&,8I"JD8(I:*    8 Z4
M  <@=:** "BBB@ HHHH , T$ ]1110 8!HHHH 0*H.0*6BB@ I B@8 I:*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45385611256096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Feb. 19, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 19,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1397316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">251 Ballardvale Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wilmington<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">222-6000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CRL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001100682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1'
ML#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,
MJ^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@
M\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^
M\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$
M%     @ >3I36I>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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MU\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK
M>MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ
M!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.
M\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( 'DZ4UH'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ >3I36A G)=SN    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ >3I36IE<G",0!@  G"<  !,
M     ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !Y.E-:
M<DO*QE4$  "2$   &               @($-"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ >3I36I^@&_"Q @  X@P   T
M     ( !F P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !Y.E-:EXJ[',
M   3 @  "P              @ %T#P  7W)E;',O+G)E;'-02P$"% ,4
M" !Y.E-:&445]3<!   G @  #P              @ %=$   >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ >3I36B0>FZ*M    ^ $  !H
M ( !P1$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
M>3I36F60>9(9 0  SP,  !,              ( !IA(  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&      D "0 ^ @  \!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="crl-20250219.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crl.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="crl-20250219.htm">crl-20250219.htm</File>
    <File>crl-20250219.xsd</File>
    <File>crl-20250219_lab.xml</File>
    <File>crl-20250219_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "crl-20250219.htm": {
   "nsprefix": "crl",
   "nsuri": "http://www.crl.com/20250219",
   "dts": {
    "inline": {
     "local": [
      "crl-20250219.htm"
     ]
    },
    "schema": {
     "local": [
      "crl-20250219.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "crl-20250219_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "crl-20250219_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.crl.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "crl-20250219.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "crl-20250219.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover page.",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.crl.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001100682-25-000009-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001100682-25-000009-xbrl.zip
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M'5 $]3\KE I+NFHQPF(D%&,$XGO'_#L9T1!];,,A+M21-U TBJ_I"J-IJG0
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M_+P#,$C-^I5$/$9[SQ6$C)HE(41.$# I/AS'FB9,C%4\)8IJKJ*I>3-[0?A
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M2!M3J0#P&MX&'@A3@^3J@RF>"2F6R(G-SX=E)F&8'8M4Q-@I'*V+;\T^??,
M-6QS9@OFV\KWB6M/>*6Z[;C@E>:^IS?OP50S0S>U1]H\LB\Q/)P)NV5"_TJ6
M@-V:7:UMM__N\?LU[WEV\E6K=KW^]-&ZYYV*W>GAHXQ@>&ABB[G0#>>N7P,
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MP1HQK+IX:*T? "-N9[Y8NE<.>?NT8W6^K*OM\DE''KPTE""9O,55$5\X1AP
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MXIWAAJ.]^QWM1_L^_-'>_P%02P,$%     @ >3I36M(0NA[G7P  1)(& !H
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M(4,[7(;^G/67KX%B;ZGK+Z/+:=VU3:_5W8ZQXVM_YDL6RP; I(!U_WQGO%N
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M064K>C:6$XW6MG,D\]T>9ST?  MO-C"] O$)&'8"HZ,86?(X$%:@J*^;\\?
M02WY8:9-3#?Y7V8>@LVN&&6U*V;.[J_09=7QL&"^;G&GS1P0O%X07X'U.0&2
M(!^ADXF9!&4]S+1#,("9#RR(PU \74R%*GO%E-"HCCO#UJKE0*+N8P"2[B^
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M<3(SJ,^2X+<J4<I)P>]+D>)CESFR&/CB9XT:\&9%!;;$<8J/7<D4V$I9CXJ
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M7&,:@RD\4SW7J\5<$\)GUZVZT(C6Y3Z(^-8&6;A%E;E@B"_E[)3_ VP@F,?
M"EY(!W,3'<R.=#!O@$ZA=NRFN@HN" 97Q3A%VA]/2LDVIR8#6? LOJD-@!1%
M%K7/0LF>TZD+3CWUMJ59WG]&3@]PWR$Q82GG9R7Y3U-8HC(+:9&SB/P?T6\7
M'7/Q6*BI%9<9E[L5T5?9&"AXH *DPBHI'=BLF@CSQ(3RE<QQE%(QF[VT@+B(
M]&)2@\AR%-*5B_R9="W6$K%A$4\3*@8O"RIFV2QJVJ4Z0E8]Q?O=XLWB@UEI
M&LXT<F#GLSP<,2E5))'X4W9:T6Y6@@I@B[GP"F:XA_&P(GB+K!\1,)T)64R#
MGY0GB,E[ "#!O<L\G$)CJQH $9",Z'+JB]#MM,WQ5!GZ?'_1Y?#Y>-&MNF;G
M<06S;NC3[.NB9_.B-3UO/R#Z33\CYFD-E"_L&>DKC:.(A>7**WK$EE""L'HK
M\82E97+[8KH-D9]%GY;OVS7=0#P(0$SRR33W8065</6 B_<ABR<Q)KGP%M5Q
M- !)DE53>*+GZD)F\TBG3W$,$R\&XZ*B@O?SJ8L[&P%_%II987FQ) $=$^!8
MQ,&>RY5RL3[S[Z!XG_K9G^(D[)/"+R_2B?CM8SQ43&\0.,VCTT!,(CMX@'-;
M,0&4I7X23%FAR"W@:@N9YRS5),BR:@$]Z5,G>K'2.WA6^0B?Q*!/G\'CH5!R
MYS3"_TF5+M?%E3L>BD"5\2-Z!#7U]/_CF7[\,?QU6L!CDG)>V"PA4*P';N8V
M/["F,?W"9MZ4BO,15W]9XB!8BN. ^\4 &+\5^30;W)RE1KI&GR.+.B4W Q^G
MGLLU^N6*NPL%.7R>Y7D!.LZ!CBS;'=,N\%&LQ+VPFA!7> !QX%Z0^B$-QBG'
MWGXNF%@^P8Q%V" 7ET6HDN<5KPW0 "4#L8E,*2X'^!J!0FN) NCZ<M7F'FJ+
M5D^JZ?8P/6?N++YC#LO>2Z7FD6I2CEA N2]4FI7>)40CS(=2%EK[<[MNOBU_
M&;(E56\K*%+ J L2!103-K)/^VS,QR&*F*DP%3ETIKR;)WL#5G*1(G(%YO4%
M[JRK* U@UJ)RUU%N<V1]P@$.1 *&7?S,BB#B(/;SPHJ=C6<HW1PB(?HKY5')
MIR*#Z1FD=%$%+>85E*0'7Q KF[D,B<+CYF"DH *YZ!E*03]$Y;(8!R#*.^!P
MD<W122"",<)O"\0J5C2*B\^/V+B#A6(8F8]$E)YR!$5-)H^"_^1LYB\2QP,"
MJ(]IO8.*:O2(?K65$<]=$'1/H="GIZ<ML="]4]?Z0IEU76 V5Z WH'<,W]</
M"OS? 8R?NBIR43 NFXD8B+O"[!=_?F)H$%;O;,@N'N)^7[F?X)269-WBNZ#,
MG@?<VDOR-&[(RL_C9!)S5OT7.N8QWXE[F<FZ;:Q]H"$;FB+4'9M:7&MV,@K8
M@&N=P(;]PF-WBP[+M0K#FWN<7*VCZWK'-BUKW3:F]VBVN_NR]R01,B"43EH2
MBFU^\)-PWWDR+W0U[@F"=/S<\6=L9!40I=>X25[C=43Y:L/I=.L5AM,9]@M=
MS6\[$@C6UE'%^KYU)I!N= S/?OV90/6\5H-]NM:+7KOYFNV935KLIM<"9)U&
M+78_D/5V6]#*QJ:Z\V[&$;ZQ?>MT&L+K<DUMIW%1YW]T[ZXO[Y6[J[\N[Y3K
M[F^W=]V'V[LK^.GJYN'R[J;[<'5[T[TF\,_SF1%7 <2"\-/$C(;5O4I73H62
MM]9S:[L0]?[\C\N+S]>7LUY6+=SD^>W-Q>7-_>6% G^[O[V^NN@^P#_N'^ _
MGRYO'NZ5VX](B+>?+I63Z]O[^_<'"8S%'HVK@7'"/?!Q#N_H8WJ.\+P/1'EE
M$47MTXRNA('D2@V]=4M?\-=<B7>@B/\P2AA3/L%]HU2Y!)-TEP& [87&$\/H
MXUIPO"%"+35=7VZ-_NW=^_<*W OF,YYEJ+LBP+Q[P_D->S]& !HJ!Z#Q&J3:
M8C!)/*L#SQJC]+S*F<GOO?1[*V6AO8O@WSBFL5Z$7]VA_;XH82FR"A?YQ8H=
MJ<HA[.O'7792W0$?S=*H+;B:1CS-F'?Y;]A..83G&[;U NJ1&+%'C#!<HJH2
M(R1&E%LPB*&:1#-<B1,2)Z8X89HJ436O=IQHD1[TI\@Z7:<'S=R\*W>W$K>;
MAQF:IQ+;L!O&*UH"6\<BIM,TV=P.V#JF15Q+D["M ;:VZQ'#4QLF*_@GG(YC
M-5QL/,09+\G956CLYB<[$-31P!C1B65N5C1V=@WNAV3;=B(:J'_.9A$O3^3M
M3L0DJND1SY4TTIP3T72/F.H^3Z1%AM/Y= Q$.=MCOI*E$=D0AW1K.Q4E1).Y
M!E#385 G8D@!+\C<-HGG?3OM<EO7B&58TKZI ;:6;1+7="1L:X"M3@RPS!U7
M6N;U0%?W+% =Z_<IM5OD3!L*@!(GQ0T.!+:)X]3O\3E&FG5-8IFF!&T=82T'
MQ(TK!7DML#54XKX!2VBGH+EG?%+F=!!,,8%O'$0![_T;/+8VG@C:G]JTW(.V
MP-8AFJE+V-813[2T!N91M02VID-<JWY?1CM%27>;2=).06)J1-<E/=:BVIE$
MU:6#IA81;;C$="1LZX&M@VF,C10C#9<AO\=Q'R='\9;A08)]']LI-73- C5.
M.K+J@"T?IZ%_D+"5>'M0L'TKO-U2#E\V"(MB;'*WZ3CDG?-WMB@UYG8Z#RZ(
M_'C,E!,<;[!+4*E5"5<GFNT0VW66-BZ3W_:@5NO$TS=[%>5YO*$JH#O$V)*=
M(L_C#3.Q-(?H]F:37J:&[BK_^."44O85Z:'O97JH3 ]=0I6K<KB3P)9V^BLT
MXLHDSYH@:WG2#UM+0A.Q'(FSM20F$\VKOQ2[Y>*B4"K:*2].=)?HAKG.;I:$
M]T*P&@8F:4JPOK:;1[>)[KH2KJ\-5\,FCJ;6"==V2HG5]B<.\VUI0/1$UXFC
M6I("7]FZ4!WB&#+SO*;@ +'T6IG;,8+5LXCU!AC;(F?E535$I_08#A<O94=&
MO[)=,B];Y0H_T8$T'4^38;O]GX6NNB#895>7IIR'9Q!-VUSF)X_C#5UIK@:6
MYS[/HT6"\$]LS)%B_0'. #KIL8@-@DP9)/'X_;<*Q /$I1.#J-(Y]/K5;,2Q
M9%UT+2D+#G%E[4Q-AK]*O"UR7DJ/.9#=L.S(LQUUS2".*;,=&W 6FNL2SY+9
MCDTY#]TB^I8\#7D<;UAUZZK$V-+UHTEFTZ'$G:Y9*II@*A5I2+,L"7JYF"^?
MQ4H4P^]1EL2\=P@6>O.,AI9:58XINX34E%)H2\C6,T5%=25DZTE\<\Q&)KYI
MS1<M2^:50A]I$)9"Y7Q$DQ"^=A? HI5K"M*;9G$2P$\\92[BC45H2."??N>[
M1/YACW/:<8_-)B0P-4UB>FOS/9JD2TO<.BS<TEP'!.#AA+@D?AT6?NDZT;=T
M8)/H)='KQ:X-QR2VWH"(</FQ];/"EW52CGR 1<+5L1EA*YLPX*%^G*,J.+>+
MVD9ERP^VV-(XIZ&?A]-&A-&2X3$!"R,%>V/9M05WC>$I?G$4AP#,%%_Q?<;)
MP13H[OW6=N+C6UB^[1'B!R2JMUFQ>U/V)#8TU.Z4&'%,&+&#I2@1XI@08A?;
M;E_!Z8:?_BPRW>W_.T\S[ V+JGG"^HR-N2ZU)B[=SK#TB0;"9FV%BPSP-;L'
MIX2MA.TAPK;5@@7,ZX2A7*&AT@]PQ&O43W?-?E(*=U$[I0THLJ[LI73(E'N,
ML-4TXFTI/96@;3;:MKF^Y'O<P*LB%3(IZK COR<X7<'V/)D4)7%+)D5)_#HH
M_%*)[AU.,WB)7H>%7H>?%'7@F4+M_^#.!]ST))J6WMHB2_"2)A&L-:WFHU7M
M.45FD+UE!IG>T9N>0O8;30-?IGXU9PLG9D?7FQ-]E:BPQW+;CMVTT(A$A_UM
M0>WH39N/*M%AC_TV.WK3FAD?C-9S$81YQOI2[VG.%J3>(U%AIO=L[D\FT>&8
MT$'J/1(=YO6>^KF#]-DV^]86^6S_YO]@_5,*JZ)#ID3YN,<2+$&HNFY3)<ZS
M-*,1;DS."WYK7^X!M%A<Z<IM1U*@I1'-D)WG:@*MH<DYP76!UFV:ZMH:T.K-
M='\=@*!8X_UJ#69(45$;:-^BQOAH02NQMB;0FE;]"@X7%3_S8C[X;S]X_/47
M^&/!@6#8L.1)G 98<7&6,.PE]<@^/ 7];%0LM_J4^,*9.GN$]M(8F??2([7!
MEK_Q+,A@S_YF:.NB? ?AO/QG"?G77:6^#0/XFKSIL9?'(M;QZR\]/+/JM>J?
M>!!!_Y_O DKUGLLLZMN^:;HZHYY.[;ZM>[;:LYC'_J6[[\J'1LD,J8;LM)<P
M^N64#C*6G-'PB3ZG\R<\#J+3*FZL/M:U"^5_B +2*<KPY$0 ;4@G*3LK__*A
M'Z23D#Z?!1$'$'_HPY@F0UA!@6>HMRS@.*<!<;E8F^=V+-?!Y15Z4?'A8N4=
MOO(%^A+7+*_CN.[:RVI'6WMMTVLUIV/;SHM>N_F3AF/5LEAG_>7J:U?JGMIJ
M5KS A'V&=5UOQ(6U!1IT5G+A\S^Z=]>7]\K=U5^7=\IU][?;N^[#[=T5_'1U
M\W!Y=]-]N+J]Z5X3^.?Y?"^RG7VQ*X"SW>USL!"]/__C\N+S]:6BKX)62S9Y
M?GMS<7ES?WFAP-_N;Z^O+KH/\(_?NM?=F_-+Y?Z/R\N'^X/<_Z+RLGK_)T&D
M9*,XAW?T4Z*PKSX#_:329G(<YU&V,%&L-<&+MFWD%5]_&.A[P7S&@QFZ2Q1=
MU<UZ8A8'!@Q#Y< PMO.MG;:Z1__2ZHUVTY1M&-JTLI)F36%5;94[\]];^\F#
M/)4US8OS),'69I2?3@,CB-\&ZT-QMI[3=*2 ]%9\_ O[3QX\TA#.85U3!9E3
MLH<M:)Y)[,8U=)$8L<>^5(Y-'.>-W(:M8WH/">TS)0&%![A=#YO/< X(SR74
M+T40X0WTXX%"PS!^HI$/MPWB1/$3U@\R!2L8&6^2_Z/F$D/5^#M^U"WBZ#J!
MEZ<3YJ/[-'QN9R3+T7'2=M,J@%H"6S[FM7[8MI.\KZ)'T&!X"ZEVDI[NN,0R
M9:BSENQ^(#W=\B3IO0AZ?R9L0L%JI9MM[(/&$$TUB*[)Q*DZ8.LZQ'4D\;T,
M>+?9"!MJS#E2VDJ"H&9[33.(VP%;UP#5L_Y<GQ>0H&8TG  ?8FRA_<T$^!W=
MV)J'/AHQ03ZJ6WP33>J)U_X3L567V%N*5M^DBUP; A5_)O$$EO-,E$E(D<RC
M/O>;3["#/G<:M53F AJ91-6DV5D3= V/.&;37+J-)L6_@.+RA"D^G6 &*"?%
M-$MHQH:!SXDR>U:"Z)&)L4DM589U]#];TAZM!;:F0=PWJ#]K$5'>@G2D&:Q6
M"1E-F<)W?QH/3G/X1R6TTDYB-#6=F)XDQEI<LQ[H'WK3O$.-)L;?X[C_%(1A
M.XE-)ZYIHW4CR:T.<B.J9Q'5;%H8LM$$=Q5E-!H&6/+2>EGGZ :!*Y+XZO#"
MVB#KWJHNL!VD=\$&+$E87\GHUU9'/TR=:&\0)#M&LC-5HC<N_MAHJA-!QS:3
M&V;;Z$;3QMFW [:&ZA'#K1^V+XDV>@VG/!%M7$UYWQ_':MQV6SWGR2&6[A)C
MBZW5I*CIMB4="9(=&)ZY1$.;7GUA=/Z5P\'E]UZY<K9!([?6?O,@-<#5]937
M >T%89 %+"7*'>LS-N8M/V[F!\9?%0/C1;'%)0_.'7*%7T/.9',U93@[&UE2
M^4:P[_H^[WJ@3.@S$H*LI&S.%C0P\ VC_LZ,LI+R8##"=HGW!AC16EZ7Y QW
M-)ZP**78!:Z=7B#-\8BIR4AC/1E,!M'?(&FBG30XC7LD[)%%^9*^T1(<,5UB
MO,%HC:.D/U,C[AM,L6DG_94RL&)KM90$#9VHLO"Q'MCJ#I!@TU)M#H4$YRL?
M6T^(V ](%F+41(AO5-W=_OK';R/#5I7<>4"@VDN#+ TO@3S0(]&(:EE$=5]8
M!?G*D:\VQ!BNXVAXFK%DK/193U0^\M#.((BP6Y8H_VBI!-:)CJEBJFQ_50]T
M;=,AFMDTKVRCR7%CW57K56+3-8CCRJ38>FK:/*(;]9L;+2+&N5STUA.?IMK$
MLZ5CJ!Y;7R.&*5/2O]D;%$[5T_;3GV<179.QD7H<LP8!&FP8_1V2/^B(_4!8
MKPYFHKW9D)&>H#<^%,NPB:INKCJ1GJ#=(5I)^HWFDWZ#,NFWG8+7U(BFRS:4
MM<Q%M;&1?L/$;J.I4*34RS3OMVMU7=CX:1;[7XCRH]I1-65"$^61ACF#@_ ^
M*"#^81EB'%ZJT#P;Q0E\I"^N1G%Y)4A3S"%!_WF<9VD&?P&8M)-K_N,'%ZR5
M#Y)M'C!LVTG3Y_%X'$<;"5K;3-$6: 2FMIFJ%<KGQI0#]\19E2,(^<WP%L-P
M7_"6E;/[6H/<UAMTXCM&IF%IC:S /P"&T8558\T##16<>W$:1&4STG92H$8\
MVR9ZXRJH6@-=U2)6,[OO'P UWK&,PH]]A=$D@O6WU.N@$5?3B28[K]4%7=<A
M^AN4>K63"!\21M,\>2ZU:)K!YM*,*/]ER=3<W:H!'Y-:*^WAPX=M.VFYZ_OY
M. ]I!C(U%C46\7B2L!&+TN"1\2&H[:3)$T-SL!_3>TF/KPM7S;.)J3MUPK5%
M/GT103\'H8E3BN^ YA+EFO;BA(KYIJ*K3D2%#4K@GWZG&'QQ;+%V@YBV1JR7
MAG5EK+V>0[& WEU9=?%J$+V)HV1KN+V=,MDBYALD0AZC5+:(X34MOUM 3N_H
M35>2A8P^7J%K$\_:YVQ!*727#L56=:([FQ.3&B9T#ZGG<ECM>+E=&J?3&9'+
M#&+^,,3>SA:[EAY1&^?O@T"SZ?*;FCQ_%R#>AI7NLN"-:SXB#/XV.#0;C[^I
MB?0K@..[!-#/&;)F^&\_>/SU%_BC7%^Q)<.&/4_BE(?QSQ(6TBQX9!^>@GXV
M*O9;?:K8CCI[A/9@Y7FV_$AMA\/?>(9)!H&_^;ATX0+'4UK^LSRWUUVEO@V%
M=%$Q.,6:\ES$0G[]I8>'5KU6_1-/(NC_\UU J=YSF45]VS=-5V?4TZG=MW7/
M5GL6\]B_#.U=^= HF7&R(3OM)8Q^.:4#$,YG-'RBS^G\$8^#Z+2*'*O/=>U"
M^1\<Z18H 6 ;TDG*SLJ_?.@'Z22DSV=!Q"'$'_HPILD05E @&AH_"TC.B4!<
MGJVMHXKU%?I6\>7B<H=?6J!/<<WH.+JU]JK:T=9>V_16R^ZXJOOJK]7LCFFO
MO[SIM9L_Z9EF/8LU=GKM2DU9LW;Q3_D,E<PW$@_: FVO[@=__D?W[OKR7KF[
M^NOR3KGN_G9[UWVXO;N"GZYN'B[O;KH/5[<WW6L"_SSOS$F/.N8":,N>F>W9
MZ0<+_/OS/RXO/E]?*L8JP+9DD^>W-Q>7-_>7%PK\[?[V^NJB^P#_N'^ _WRZ
MO'FX5VX_*N?=^S^4C]>W?]\?)"1VF[UP$D1*-HIS>$<_?5\[+37]UAU=#J^Q
M$J]I&./MA# /3RQ\9,HGN'&4*I=1G_6WDT?=9_DMED"SP5NF+2EE,M,.E5@[
M[?XXH;@R[^OU472O7H?=0').TY$R"..G5!$V:C14LEB)ITV?J ]VZ^8B^]='
MN=?&SIJ9>:/.>4UXEV5*$/GQ^ #&QNRVHR;/"-EM![I%]#?H /(BYZM$AS??
M@>FJQ' :TR'XV_G?WK-/=X-SM__O/,W&#$=I@:A+F!]'?H!AMBF/Q-_Q7SY*
MQTD2/P:@SRJ]YY5R\7 KXUM[Q!=L L<:\/1%'B2EXQ@6]]]#G".TVXX-6R..
MV31AT@[0:B;1],:D,;66:'^/X_Y3$(9*,)[0($$&W4I2U34,<LHBNQI V["J
MG-:2*F_1'@:/V#T"Y\172/;0ZG9VV["EO<D4G2,D65,CWANTWSAVBKW'HMG3
M'DT/>ZCF;INU/>(VSK'2"L@Z.E'-O5>PE_DM41RQS8?1O#N/G1%-.]B7GA;Z
M%=[=2C9T8CO$U%U9ZONZ4+54XJE& PI]6TNC?R=!QI1^_!1A-XT@>@2]GI<%
MMY),39MXGFQR7X<>UJ3IVZVEUI/?:1"]YSTSE#A2D%CSA)7]XKC[.\T2FK%A
MX!?50IRFBQ@('[#62L+6=# MI9^M#I3S<*IP$YIMM):J_\2H8XKQJT&<*#YH
MS$'&:;RE4E@SB>/(T<-U0-8E>G,F@+>68*\+^=L/4+0&*(-;+%MM2W;,J &L
MGKUW5WCS7&;2N;8K^O )=>UE.H9!=$OZ]>O0$8CJ-&869+LRK\]'-!KBM(5(
MQ,I%UXY*JP^9/]BX,WM(:)]A9B@+'K%X6IP9[\%"_:PXQ_;R65TCMAS[68OC
M!$28:9C2<5(?B*]:'J[0;.*JTE%22[Q6)X:J2>*LL?;"]^,<"R\F]!D%:RLI
M]$0SB>[4BD?'2)VZVI &WVVFSB0_A@3!$]TAMEJK&G:$%*KIQ#3KG^!U[%0Z
MS:!+&&BZ>3MEJ.822Y:SU</[L%)0YL_5Z?++4_@VGVI3>(SZC/=U;*=%:A/+
ME09I+8:$12Q;>HOJCIBM<<RWU\%[8FG$\^00JE<.3[K$-NMWF]=+LIJ[Q\D8
MN_<RVJDSQ_=,S5#59LUHV+$^RS")Y6RVP6KOC_W=I-^R0[%=@[C>YJJYIDS-
M.-38^S=UMQ/9[SOR"MG=[J 4NJ[_GSP0+?2Q>*F7IW +9DV+/D"SR#U>Y5*$
MXA/)0K_2MN@D)Q8Q'4\J>J]LEWDF<=Q:]>=CI^/SHGR)?9VPJ"_2J=M)H;JA
M$\^N-;!UC#1JH NYWNKK8Z?1/_/$'U&4K469<-E6<9HM%_1RE,2\T>)B86+E
M@782MJ43U[$E7;\R5$VB:U+TUEMZZ#/63Y5!$H^5E(9L@;Y;2:ZF1FRW_NCU
M$9*L36Q[[VD!S2M6DF5-LJQ)<!YBR?GC]9A61/<..'QZ2+&8/.4]O;[-M]I:
ME_^);EI$==<J_S(&\^9F@VT0S5IK-\CXRQO&7P9!1"-?QE_:J*O-&X\A-HK.
M6#)6^JR7<;]0PA[C\!$/OVAJ,Z ^)MPLC;!OA0JB@130B.7*5-8ZLAT<FQB6
ML6_3\LAHFGUEB1\47M\4^THK\81[>5M)P;I!7*?^EL='2+ZZ12QO[XZA]E,O
M?191F3A:D,=DO3 F7%8+18TI(:,I4^(>[(6VE])/-&)Z!G%LF2_QRH!U+8W8
M]8;"CI[*BU@L"N4L 7K-DV<AG5M*JYI'-$>FL+^ZWVJ3ET3&:62<9B=-8\#3
M/V '\$_\:QKT>7I^2^O)WVKNV%%R).)HLB?+6V5QX0Z03#'SLFP5#_8"2]O<
M[^Q$TW$BH]0E7A>JF"-]P-'7YE-NR_,B3@PPR$U=DN5KDZ5F'G#^Y"$F17Q3
MP'.'&/Q!!N!Q;M?Z_EV[[;5YZ1"'>!2N12Q]K4Y=[TFT/ ]B-<0O!P/F\XI#
M]M7G_: 5',BD^$5OZ#CB_(((KH&*]R,-Q7 F$3)/LR3P,VS-!C>T4]AK#C$=
MV9+M=:'J$M6LOS7/4=(T%_*"EH/7)M]621O'Q3%L4N[O_21,@^BV_;(V%%+V
MO[R0>6?.0)0>&P91A(8"Z H3^%[<SK8$NFL2TY6S&>L K:D179-"O[:$YIV)
MF<&/:\EXGN&*/9T9<!;]..^%;)ID_'UY^$UCAC_6#X9F$Z<*IK>SF>^]'BS>
MAFM*3#Y*3-Y!@N\?D[F0^CG#41/PWW[P^.LO\$>YOF)#A@T[YOUY@QC>R@M5
M'MF'IZ"?C8K=5I\JMJ/.'J$]6'F>+3_RRB>CJ>71\#>>81N-P-]\6+K(3\!3
M6OZS/+?77:6^#8'XFC1MBC7EN8B%_/I+#P^M>JWZ)YY$T/_GNX!2O><RB_JV
M;YJNSJBG4[MOZYZM]BSFL7\9YKORH5$RXV)#=MI+&/UR2@<92\YH^$2?T_DC
M'@?1:14Y5I_KVH7R/SC2+5 "P#:DDY2=E7_Y4*81!1&'$'_HPY@F8 :4=(/!
MC@4DYT0@+L_6UE'%^@J=K/AR<;G#+RW0I[AF=&S=7GM5[6AKKVU\JP'KL5[T
MVLW77,U[]<5J<-%<?_GEBP7$/)S%2LB^?+&;7NMV-&<W2EAM4ZF[6$H^PSR=
MM]$0-&TW8^F/[MWUY;UR=_77Y9URW?WM]J[[<'MW!3]=W3Q<WMUT'ZYN;[K7
M!/YYWGGI!,P"9@LR7;/X':]FF\I;FW5KNRCE_OR/RXO/UY>*^9U4T!)XW%V>
MW]Z<7UU?<0ZAW'Y4?N]V_U0>;I6;VYM3_/L>X+31 JTHCTN@W1=275Y?GC]<
M7BB_?;Z_NKF\OU?N+W__='GS .SVX^W=)P';D\\WW<\75W#?^UJL :>#K'CK
M<E?87V@5GAH==X7^VZ,IPS=@V/C]@@;>4L)1=SKSDR!2LE&<PSOZ*<%L P:6
M\X0EN%:P?-*E,)P4L_+6;Z6.?2_:.U#J?!@EC"F?X+Y1JEQ&_0T]QX\!&D\L
M?'P=<#0337=H([/HY&SXD5TPGXU[+%%TERBZJN^BKF[?^S$"T% Y (W78  M
M!I/$LSWCV4K.:C<K=+\C3.Y8RFCBCT#B]%DHFI3?L^0Q\'?J/O:J6/36XD5^
M[ZT4AV91PNK8[=V6P<$[Q_P;%+7?<>OKPO9-"+SON 5=-8EN-:U3N<2(_6U!
M\RSB-*[%H,2(_6W!U3UB;)D#*3'BF##"\71BF/7WRI3*U[:B_>F@VB#RX_'W
M:&$-SU??57H9Q-F2$BM+ 5X&6L,AJM8HFF\-:#7-)*;6-)VK);"U3&)OJ523
MLFH/LDJAJ4*5G["J)?EN'T([<-7NU*IE[V-+/QW]H6INI]:!3/)4]Z-H=FKM
MXRY/=3_.KXXE3_6HU91NOZ_TJ/_E'S]8[A(6-#$?Y)ANW3]*UEF(MZ4M\.JR
M._%G=QS#>O_+NR*+\5BLC].QJ/^?/!#)L*E22TZNW5E,R5VU_O4IN9LS<O7O
MS,AMCV32B*$WS0??#M!:Q+#DR-1:7(8N42TY[JB6P+U&'%-O$FBE;%XGFV<R
MF.>)81/TH1A@<%J*:MK_=YYF8N#! 8II0XII@0F>#)#4(DAD<*06N)J&C)76
M(IVE<&[",6R6R_<,UHHC":7;D^BZ9 3UJ.FU^I./%JXF\50)V7IX@=:L7JHM
MGO%WS'=*C62%1A+@'(<XXD5)=.8P&$]HD(SY^,,138:O4V)VT%Q*5XFF2Z=M
M/;:+[DG(UN+%\(BJ2T?&42"MU%I:>>=Q:BT/<49#!># VZ7-!2NR6(E?KPBE
MN'PHW;V_L^*K\=V[=Y5K.G'LS=RWT6WF)9X=!IZY1',WSR*1:";1[!7JG8FY
M9>:-Q#.)9]]OLSC$LS?G"S0)SXY3]5VL6N-]4,,<U[]2(:Y1^3T&$CXD^C5M
M8ADO5'L;*"0D>C5K<Z9%-&]SQK=$+XE>+R]ULXFK;XZA2_R2^/7RLF>=V%M"
M=(W!K^/4;6]*_771@RM;,RP;:[JL]V[AJ1J=6N.Q\E3W=*JRCTH;3[76O,2#
M.E4Y0><8;SU.-?6"31+F![-\2%II=B#[CJ_92;,9GZX2QVY4A91$B/VZ"TRB
MVXVJ.Y (L=\>TP9Q-<DA)$),V[18Q&I6:^?C5,?.Z23 =%#V=<*B?I#ER7?5
MHTB2VFL&BN4UK2!!(L0>M3"'J%:C>*Q$B/UVI#:)9FS.A90(<4P(8>F@EC>Q
MTDJZ0H_JUA;-$KT(4C^&!3V+*:)TP+)GI9NF+$TQI53V(&[6K<=I]<DQGX<L
MM6W5((;9*+$M,6*_&*'CF,^FM5"2&+'/%@JFI1&]6<V?)$[L&2=LS2*VWJBN
MML>I@,E1GTL2C+BR;W\];F#=!D$@&_?74M9EZL32FB9DVP%;6[6)ZLA9GWL_
M"#GK<SN/53NUQE7VL2>9I*ZKG5ISEN2I[H5675DFU+Y3U0U)JT>NIW3EL,_F
MWKI_E&SJ0#$Y[+/EDDDGAMJTO,QV@%;SB.G(.:JU]$W4B*HU*E+0&M Z&)QK
M%-9*X2RG?1Z]G/:(;33*V]P:R.J6A&M-!1Z:(65T+5WPB>DV*AR]?Q'=/.DL
M9W[.FNFK7M/2_]H!68TX6]H"2\B^4"MPB67)M)1ZI)=C-BHI10[0:N6=4BF1
M8S^_PP]&3*MIU<CM@*QF$%>5H*T%M!K1]*9U,FH':'6+J+(XX2#\X@^C(.F?
M3FB2/2LA&](0]IQF*9=T/FR%!K-8-LC#\4%ZQDWI&2_,"9?8C>L;T@[0>HWK
MV-0.N)H>L4WI7*A';3=<&;W>^S'(,<YR'N6FB( -=LIF'V"3YE%*/#M0/#-L
MHMLO'&PG\4SBV>Y5.PXQ'3G(>>\'T7I$TW2B>IL3EIJ$:,>I_39HDK,DXT:2
ML>D2SWGAQ$HI+R2B[8QHMDXLZX6C=R6B243;O4621SQ7:L![/XBV(YJCN41S
M-L>XFX1HQZD!RWG/WY!98,H9LBT\55O.D&WAJ5J25EMXJDZGUOJ4@SI5.>3D
M&&\]3C55SGMN7R-QTR-NLQI82(38+T)81)4((1&BTI@)RR2:UO5!8L0^>U68
MQ&GDK,$C4\CDQ.?6T)3A$$U.^)$(457,3:UIA3H2(?8Y^\4E1N.Z;TF,V.=,
M Y.XS2HZD^[08[RU13.?/]$H'U ?5&F,PM_'8<Z[=LL6],VZ]3CM/3GK^9#%
MM>:9Q#,;U11#8L3>7:M>XT8.2HS88[ZF[1'#:%I/(HD1^YPPH!&S65+C.)6O
MI=&9)V&<IN^//AWL1'.Q:D9?@L3>V%4[X&I8Q#)E(^A:4-8!GFH9$F-?N4^)
M2PQ=AH7W?@YK))4L)EEF!)[1L6MB _O8CTQ.UUR9G-Z^4SWQ.G5):WF@^PEF
MRQ'/1ZZE=.6(Y^;>NG^4;&BW;#GBN>6225>)ILINPS7-6U#=1GFR6P-:2R>F
MTZA,L-: UK2(X34*:Z5PEB.>CUY.6XTBR=: 5=.;5OO9$K@24\X>K:>7'C&U
M1N'L_L5S\R2S'.\\F^>J-JMDHS60U8C3N,8%+8&L1C1'@K86-9:X:J/2/?<O
MO1IJ7/X>Q_VG( RKXW\/T("TI %9.'HUB\ 7FD1[K8'M/WYP=4W_(&$K\?:@
M8-M O-V_/&Z>*+X/,@8[C'BK\ED[PHI@]D<T&7Y7,YQV(+2N-JUA1$O@VJSV
M5ZV!*]CPG@R^U^-W,HQ&F?#[%VP--30?1D'2/YW0)'M60C:D(>PY/<QHI2F-
MS<8JEJV!K8RK290],-BZ1#<:E;^P?V&\CV-XB+%[ZJH9HYC2NSB,2<X=/;+A
M:;KA$M/:;(XT:7B:1+0#133-(+HNQX[N_1S:CF>ZJQ'7E8BV]X-H.Z+9'M%<
M.76TV4BXV":"*.RK'^:X_I4Z<8WZ[S&0\"'1KV41;TOD:+=]-D-(2/1JUN9,
MESC.Y@R&0T*O(\&P T,R75.)N:659I.4$(EH!XIHFN402]N<T]\D1#M.;?>F
MU&@7W;JR+=H*/X&<V]W"4[4ZM<Z3DJ>ZEU-UY*FV\%2U3JUI< =UJG*HU#'>
M>IQJZ@6;),P/9DGMM-)P3 [^6;.39C,^W2..V[2L9HD0>^TQ9ZA-:^TO$6*/
M^8 >\6PY[%<BQ'3J#R#$E@"Z]!J^P3F<TTF .:+LZX1%_2#+D^\J*I0DM4<W
M/0A=O6EETQ(A]MO59DLRG$2(8T((PR56XQHK2(388QJ42S2C46JY=(4>XZTK
M=6^[X0JULY*D/D<T#&.?MV(^CY-)G,!?E5M8XHC1OE2M#Y)/GM@:<6RS.?,4
M)3+L$QDLXND2&20R(#+HJ$/IFL0&B0V(#89&7$UM"#8<ITNS*^>N-??6_:-D
M0YLBR=$NQY/\AAI#T]QP[8"L3DR[45'%UD!6LX@K&U'5%:<Q]49A[?ZE=/,$
MM)SP,@TCJ9(/U*(6N!*N=<#5(Y8INT0? <9N$5O]()V$]/DLBM$<V?1V>6>3
M[JQ-&Q%$9C1<+9'# '96I.4,2MDK]^!@*['VB+#V."WK7?L0\RSTM,Y&Q,?0
M7N:0>LMXQ+5?V("X@?V+)'8U:W,&,:P7]BV2V"6Q:UNPR2:NOCE[6J*71*\7
MVP4Z,5[:=4VV7'N+$ZKF>OO37.^XR/66[88E*9=Y@99&7,]>EQ;8&#*6J'5X
MJ&7KQ'(,B5H2M6K)9M8]1^*6Q*W7QRW-(Z;G-1ZW9$'J,=[:HH)4[GN791#-
MNO4X[>6[[VX_OFLLLG%;;T%QFT94%6P-LVFQ:HD3>\4)S2"FT[3T2HD3>QQ^
M1%03N_M)/B%Q8H83F@[V7K,*!XY3"5N<BJB<A'&:+MGA1Y<L=J+9#K'=M=XN
MF83WTMG/.O&:5=[6&MCJND,,L]911D<+6UMSB&YOCK]+@;4_@27'FJT289VZ
MY-<^]B/')&E&IU8.)$]U'Q"P.K7Z2^2A[H54S4ZMUNU!G>IQ:BI=V7FLN;?N
M'R6;VGFL,H!-*5N-9;%"9QW)#K+=F"[;C17JAD$<HVD1FG: UK"(IS7*J=T:
MT&J.1BQ3^@WK,2L]8GF-@JT4S[(QZ-%+:LTAGMHHLFP-: VB65('J@6R)G'-
M1L5)6@-:W22JTZA.P?L7T\V3T+(S:*5DV=&:-G&P': UB=VXT7WM@*QE$LV5
MJD%-G:WM+2T,CDY^-=3,_#V.^T]!&%;[2AZ@*6E)4[)0'36+J%)B'$M?P=;
M5N+M4>'M_N5Q\T2Q;/B\,[/PB*YO;A\I><4+57>;&#)KOZYXO.%*"5?/:!IB
M6XV*Q^]?P#74X'P8!4G_=$*3[%D)V9"&L.<T2[FH\V$K-)AE(X% '!]D9-.4
MYFA!F"ZQC<V]4B7/>W$-OB&E22T^=X_8IE0O:QHG:3=K!NK^!?4^SF'7R0RB
M]*[&EK7J<?3H6]IFL\G4L!VB;XGH[KS7M^&/$M$.$=%LT&+TS87L$L\DGGV_
M[\5QB>5)1-O[0;0=T71=(Y:UV8':)$0[3O5WL;>$G-D@.U27%JKG$6M+<*DQ
M7:HE?AT@?AG$V]),5>*7Q*\7SV97+< O.9Y,XE=-^&6XQ-6,P\"OX]1N;TH-
M=M&/*WNGK1#'LGU/*T]5]D]KXZE*6FW=J>IJ9[,V<4RG*L=.'>.MQZFF7K!)
MPOQ@ENE.*QW)Y+"@-3MI-N/35)UH:M,2_B1&[-,?12Q-(H1$B%END4:<QC6.
MD1BQ1XS0<$Y0HWC$<6IDYW028%XH^SIA43_(\N2[B@TE3>UO"XY%;*UIW4TD
M0NP1(5QBZ+4Z6B1"'!1"Z#B@RV[:$"F)$?O4P]RMJ4_[T<.D/_2H;MU1^]Z1
M+63QY!TOARZ?']-D&$0\/4%?$1UY;>JKM]18VU9JK#O?![B]&"(CFH3PNCL
M0Z+ Z^B0\0XH/=@V>X0KV8C"JO+)).07:/(\2]P=!!&-_  ,F3&C*1HQRB2)
M'X,^4_*4#?)0":)!G(R%YQE'7H1A_ 0_PHNS..$E<$.L0Z?X@@@@AL_D49\E
M:48CGB4<#Y0X3P#*":ND6<"G\K H9A_D:#_AE],)\[.4*$]!-HKS#-;.%#88
MP(_\-8.,1:<Q@" #$)8]7O@K8K@S*:K@GT:!/U(H?B[/4MP+?C_";83E"N((
MOH(=9((T0VCA!_G7 ((1OBDJ7E.!Z!1$?,VP'9]B.3X^=1Z/ 8.>>?L@YP,
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MAO^,LG'XZ_\/4$L! A0#%     @ >3I36A/ZLG8/#P  "6,  !
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L<3(T96%R;FEN9W-R96QE87-E+FAT;5!+!08     !0 % $@!   K@P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>crl-20250219_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="crl-20250219.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001100682</identifier>
        </entity>
        <period>
            <startDate>2025-02-19</startDate>
            <endDate>2025-02-19</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001100682</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-02-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-15943</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">06-1397316</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">251 Ballardvale Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Wilmington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">01887</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">781</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">222-6000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-13">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-14">CRL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-15">NYSE</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="c-1" id="f-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-17">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
